syndrome	score	normalized_score
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	2.019360792	100.0
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	1.1008438820000002	54.51447241925058
NETHERTON SYNDROME; NETH	1.100843882	54.51447241925057
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	1.1	54.47268285874494
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	1.1	54.47268285874494
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	1.091752982	54.06428540779552
TREMOR, HEREDITARY ESSENTIAL, 5; ETM5	1.0667311	52.82518627805466
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	1.02309351	50.664225731882
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.022120482	50.61604078128501
TRICARBOXYLIC ACID CYCLE, DEFECT OF	1.0188679	50.45497090150496
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	1.00900901	49.966752548496544
SENGERS SYNDROME	1.00900901	49.966752548496544
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	1.0074104799999999	49.88759235056
YOU-HOOVER-FONG SYNDROME; YHFS	1.002119392	49.62557438819481
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	1.00127551	49.58378482768917
OCULOSKELETODENTAL SYNDROME; OCSKD	1.000843882	49.562410341182854
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	1.000843882	49.562410341182854
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	1.0	49.52062078067721
BARTH SYNDROME; BTHS	1.0	49.52062078067721
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	1.0	49.52062078067721
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	1.0	49.52062078067721
#601894 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2;;GLOMERULAR NEPHRITIS, FAMILIAL, WITH FIBRONECTIN DEPOSITS;;FIBRONECTIN GLOMERULOPATHY	1.0	49.52062078067721
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	1.0	49.52062078067721
#602088 NEPHRONOPHTHISIS 2; NPHP2;;NPH2	1.0	49.52062078067721
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.958333	47.457245074608736
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.845287982	41.859185607085905
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.844461402	41.81825285236101
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.642857	31.834677713203813
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.625843882	30.992177548428895
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.616948582	30.55167677039854
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.5333333	26.410996099007157
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.5297616	26.23412329776481
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.5262755100000001	26.0614899568675
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.525843882	26.040115470361176
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.5254957619999999	26.022876351855
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.5221204819999999	25.855730390946402
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5212766	25.813940830440764
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.517510582	25.62744528120956
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.515769282	25.541215024244167
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.509852892	25.248231718663572
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.502119392	24.865263997856207
BARDET-BIEDL SYNDROME 1; BBS1	0.500843882	24.802099950844244
BRANCHIOOTORENAL SYNDROME 1	0.5	24.760310390338606
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.5	24.760310390338606
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.5	24.760310390338606
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.5	24.760310390338606
%109160 AZOTEMIA, FAMILIAL	0.5	24.760310390338606
RENAL TUBULAR ACIDOSIS III	0.5	24.760310390338606
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.5	24.760310390338606
ACROKERATODERMA, HEREDITARY PAPULOTRANSLUCENT	0.5	24.760310390338606
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.5	24.760310390338606
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.5	24.760310390338606
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.5	24.760310390338606
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.40694149999999996	20.151995701419953
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.375	18.570232792753956
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.35073162	17.368447549812586
ANGELMAN SYNDROME	0.349102282	17.287761720591035
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.335452392	16.61181069420308
AL KAISSI SYNDROME; ALKAS	0.335452392	16.61181069420308
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.335452392	16.61181069420308
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.334176882	16.548646647191116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.334176882	16.548646647191116
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.334176882	16.548646647191116
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.333333	16.50685708668548
#603358 GRACILE SYNDROME;;GROWTH RETARDATION, AMINO ACIDURIA, CHOLESTASIS, IRON OVERLOAD, LACTICACIDOSIS, AND EARLY DEATH;;FINNISH LETHAL NEONATAL METABOLIC SYNDROME; FLNMS;;LACTIC ACIDOSIS, FINNISH, WITH HEPATIC HEMOSIDEROSIS;;FELLMAN SYNDROME	0.333333	16.50685708668548
LACTIC ACIDOSIS, CHRONIC ADULT FORM	0.333333	16.50685708668548
CANAVAN DISEASE	0.333333	16.50685708668548
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.333333	16.50685708668548
CYSTINOSIS, NEPHROPATHIC; CTNS	0.333333	16.50685708668548
PSEUDOHYPOALDOSTERONISM, TYPE II	0.333333	16.50685708668548
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.31079951	15.390984673530294
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.30000000000000004	14.856186234203166
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.29642860000000004	14.679328289147056
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.29255602	14.48755572352422
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.291667	14.44353090123778
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.291667	14.44353090123778
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.291667	14.44353090123778
SPINOCEREBELLAR ATAXIA 12	0.27777799999999997	13.755738999214953
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	12.380155195169303
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.25	12.380155195169303
HYPERPARATHYROIDISM 2	0.25	12.380155195169303
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.25	12.380155195169303
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	12.380155195169303
ALPHA-METHYLACETOACETIC ACIDURIA	0.25	12.380155195169303
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.25	12.380155195169303
DYSTONIA 6, TORSION	0.25	12.380155195169303
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.234390892	11.607182477176668
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.225	11.142139675652373
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.219711782	10.880263837468823
CORNELIA DE LANGE SYNDROME 3	0.215769282	10.685028790041002
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.21492540000000002	10.643239229535363
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.21195498200000001	10.496142286197266
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.211111	10.454347773629546
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.20277810000000002	10.041697392726242
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.200843882	9.945913716641082
Jawad syndrome	0.200843882	9.945913716641082
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.2	9.904124156135444
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.2	9.904124156135444
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.2	9.904124156135444
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.2	9.904124156135444
#613370 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10	0.2	9.904124156135444
DYSTONIA 16; DYT16	0.1883115	9.325302380140498
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.17779540200000002	8.804538678990061
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.17521401	8.676706544671784
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.17280197	8.55726082652396
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.17280197	8.55726082652396
TREMOR, HEREDITARY ESSENTIAL, 1	0.1704545	8.441012654859945
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.168786392	8.35840691117073
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.167510882	8.295242864158768
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.167510882	8.295242864158768
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.166667	8.25345330365313
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.166667	8.25345330365313
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.166667	8.25345330365313
ARTERIAL TORTUOSITY SYNDROME	0.166667	8.25345330365313
#607398 GLUCOCORTICOID DEFICIENCY 2; GCCD2;;FAMILIAL GLUCOCORTICOID DEFICIENCY 2; FGD2	0.166667	8.25345330365313
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.166667	8.25345330365313
STORMORKEN SYNDROME; STRMK	0.166667	8.25345330365313
%609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3;;FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3;;GLUCOCORTICOID DEFICIENCY 2, FORMERLY; GCCD2, FORMERLY	0.166667	8.25345330365313
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.166667	8.25345330365313
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.166667	8.25345330365313
HUNTINGTON DISEASE-LIKE 2	0.166667	8.25345330365313
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.16497748199999998	8.169787323473
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.16497748199999998	8.169787323473
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.1641336	8.127997762967361
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.159504602	7.8987669084148475
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.15874261	7.861032591544939
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.15694149999999998	7.771840506250652
GALACTOSEMIA	0.15694149999999998	7.771840506250652
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.15694149999999998	7.771840506250652
SPINOCEREBELLAR ATAXIA 27; SCA27	0.1565655	7.753220752837119
PYRUVATE CARBOXYLASE DEFICIENCY	0.154511002	7.651480736484459
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.153985402	7.6254526982021344
PELIZAEUS-MERZBACHER DISEASE	0.15111136199999997	7.483128453253636
METHYLMALONIC ACIDURIA, CBLA TYPE	0.146063352	7.233147864346572
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.14497639199999998	7.179320930382804
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.14497639199999998	7.179320930382804
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.14497639199999998	7.179320930382804
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.14370088199999997	7.116156883370843
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.14370088199999997	7.116156883370843
Pontine tegmental cap dysplasia	0.14370088199999997	7.116156883370843
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.14370088199999997	7.116156883370843
BRUNNER SYNDROME; BRNRS	0.14285699999999998	7.0743673228652035
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.14285699999999998	7.0743673228652035
#614491 PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	0.14285699999999998	7.0743673228652035
#611302 SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2	0.14285699999999998	7.0743673228652035
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.14285699999999998	7.0743673228652035
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.14285699999999998	7.0743673228652035
#614495 PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D;;FAMILIAL HYPERKALEMIC HYPERTENSION; FHHT	0.14285699999999998	7.0743673228652035
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.14285699999999998	7.0743673228652035
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.14285699999999998	7.0743673228652035
METHYLMALONIC ACIDURIA, CBLB TYPE	0.13992838200000002	6.92934034147574
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.139928382	6.929340341475738
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.13641109199999998	6.7551619572100705
GLYCEROL KINASE DEFICIENCY; GKD	0.13581648200000002	6.725716500887674
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.1333978	6.605941866776624
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.1323876	6.555916135663982
SAY SYNDROME	0.12627551	6.2532416445966135
OCULOECTODERMAL SYNDROME; OES	0.125843882	6.2318671580902905
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.12508628200000002	6.194350335786851
LOWE OCULOCEREBRORENAL SYNDROME	0.125	6.190077597584652
Fabry disease	0.125	6.190077597584652
DYSTONIA 7, TORSION	0.125	6.190077597584652
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.125	6.190077597584652
SPINAL MUSCULAR ATROPHY, TYPE II	0.125	6.190077597584652
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.125	6.190077597584652
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.125	6.190077597584652
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.125	6.190077597584652
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.125	6.190077597584652
SPINAL MUSCULAR ATROPHY, TYPE IV	0.125	6.190077597584652
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.125	6.190077597584652
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.125	6.190077597584652
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.122338862	6.058296391841602
DERMATITIS, ATOPIC	0.12132303	6.007991760592725
HYPOTONIA-CYSTINURIA SYNDROME	0.12050189199999999	5.96732849708612
GLYCOGEN STORAGE DISEASE 0, LIVER	0.12012000999999999	5.948417463381154
ALAGILLE SYNDROME 1; ALGS1	0.11886790000000001	5.886412198895462
IMMUNODEFICIENCY 23; IMD23	0.11808528200000001	5.84765646970133
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.11808528200000001	5.84765646970133
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.11724596999999999	5.8060932184326575
IGE RESPONSIVENESS, ATOPIC	0.11724140000000001	5.80586690919569
#251120 METHYLMALONYL-CoA EPIMERASE DEFICIENCY;;METHYLMALONYL-CoA RACEMASE DEFICIENCY;;METHYLMALONIC ACIDURIA III, FORMERLYMETHYLMALONYL-CoA EPIMERASE DEFICIENCY WITH SEPIAPTERIN REDUCTASEDEFICIENCY, INCLUDED	0.1140845	5.6495352614531695
#300867 KABUKI SYNDROME 2; KABUK2	0.11323039199999999	5.607239303079426
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.1121212	5.552311426674466
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.1111111	5.502290647623904
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.11111099999999999	5.502285695561826
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.11111099999999999	5.502285695561826
#615034 DYSTONIA 24; DYT24	0.11111099999999999	5.502285695561826
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.11111099999999999	5.502285695561826
DYSTONIA 23; DYT23	0.11111099999999999	5.502285695561826
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.11111099999999999	5.502285695561826
BECKWITH-WIEDEMANN SYNDROME	0.11111099999999999	5.502285695561826
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.11111099999999999	5.502285695561826
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.10939089200000002	5.417104879592018
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.10583748200000001	5.2411378105037505
VICI SYNDROME; VICIS	0.102119392	5.0570156855853226
WHITE-SUTTON SYNDROME; WHSUS	0.102119392	5.0570156855853226
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.10127551	5.015226125079683
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.10084388200000001	4.993851638573362
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.10084388200000001	4.993851638573362
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.10084388200000001	4.993851638573362
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.10084388200000001	4.993851638573362
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.10084388200000001	4.993851638573362
EOSINOPHILOPENIA	0.1	4.952062078067722
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	4.952062078067722
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.1	4.952062078067722
IMMUNODEFICIENCY 58; IMD58	0.1	4.952062078067722
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.1	4.952062078067722
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	4.952062078067722
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.1	4.952062078067722
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	4.952062078067722
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	4.952062078067722
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	4.952062078067722
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	4.952062078067722
TIGLIC ACIDEMIA	0.1	4.952062078067722
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.1	4.952062078067722
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.1	4.952062078067722
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.1	4.952062078067722
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.09727248200000001	4.816993693517251
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.09175298200000001	4.543664627118303
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.09110401200000001	4.511527229850267
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0909091	4.501875066612663
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0909091	4.501875066612663
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.089828502	4.448363182838304
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.087632492	4.33961540439773
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.087632492	4.33961540439773
KEARNS-SAYRE SYNDROME; KSS	0.08125112000000001	4.023605901525299
PROPIONIC ACIDEMIA	0.07682789200000001	3.804564905110825
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.07567571	3.7475081372185017
PARKINSON DISEASE, LATE-ONSET; PD	0.07280167	3.6051838922700052
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.07142860000000001	3.537188613494681
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.07142860000000001	3.537188613494681
ALAGILLE SYNDROME 2	0.07142860000000001	3.537188613494681
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.07142860000000001	3.537188613494681
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.07142860000000001	3.537188613494681
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.070811472	3.506628051833543
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.069871012	3.460055888814147
WAISMAN SYNDROME; WSMN	0.067510582	3.343165929904813
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.0667311	3.304565497377449
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0666667	3.3013763693991733
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0666667	3.3013763693991733
#614251 PARKINSON DISEASE 18; PARK18	0.0666667	3.3013763693991733
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0666667	3.3013763693991733
#607688 PARKINSON DISEASE 11, AUTOSOMAL DOMINANT; PARK11	0.0666667	3.3013763693991733
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.0666667	3.3013763693991733
PARKINSONISM WITH SPASTICITY, X-LINKED	0.0666667	3.3013763693991733
#606703 DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM	0.0666667	3.3013763693991733
#614203 PARKINSON DISEASE 17; PARK17	0.0666667	3.3013763693991733
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.0666667	3.3013763693991733
COWDEN SYNDROME 5; CWS5	0.0597381	2.9582677962581734
COWDEN SYNDROME 6; CWS6	0.0597381	2.9582677962581734
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.05920461	2.93184904027789
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.05791603	2.8680377587523247
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0573294	2.8389874769837564
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.055786512	2.762582705428699
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.054415282	2.694678544595611
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.054415282	2.694678544595611
CITRULLINEMIA, CLASSIC	0.054415282	2.694678544595611
NAVAJO NEUROHEPATOPATHY	0.05383529200000001	2.665957079749026
SMITH-MAGENIS SYNDROME; SMS	0.05304508200000001	2.6268253900019274
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.052314992000000005	2.5906708799761624
RHEUMATOID ARTHRITIS	0.0522012	2.585035829496287
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.051715192	2.560968411631912
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.051039482	2.5275068329642005
HYPOADRENOCORTICISM, FAMILIAL	0.0495726	2.4548659257121996
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.04822951	2.3883552751478794
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.046298382	2.292724617780932
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.046298382	2.292724617780932
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.046177702	2.28674846926512
#614782 TREMOR, HEREDITARY ESSENTIAL, 4; ETM4	0.0454545	2.2509350572752926
GILLESPIE SYNDROME; GLSP	0.0454545	2.2509350572752926
DYSTONIA 27; DYT27	0.0454545	2.2509350572752926
DYSTONIA, DOPA-RESPONSIVE; DRD	0.0454545	2.2509350572752926
#535000 LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON	0.0454545	2.2509350572752926
SPINOCEREBELLAR ATAXIA 15	0.0454545	2.2509350572752926
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0454545	2.2509350572752926
#608627 AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8	0.0454545	2.2509350572752926
#609270 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7	0.0454545	2.2509350572752926
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0454545	2.2509350572752926
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0454545	2.2509350572752926
#607346 SPINOCEREBELLAR ATAXIA 19; SCA19;;SPINOCEREBELLAR ATAXIA 22; SCA22	0.0454545	2.2509350572752926
SPINOCEREBELLAR ATAXIA 20	0.0454545	2.2509350572752926
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.044675412	2.2123541358725163
Growth hormone deficiency, isolated, type IA	0.0444444	2.2009142782247304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.044436402	2.2005182122997264
#603471 CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2;;CITRIN DEFICIENCY	0.0438679	2.17236564034467
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.043595502	2.1588763222852547
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.043595502	2.1588763222852547
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.043399902000000004	2.149190088860555
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.040988382000000004	2.029770121435536
POTOCKI-LUPSKI SYNDROME	0.040580892	2.0095909636736176
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.039928382	1.977278263408018
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.039305382	1.9464269166616561
SILVER-RUSSELL SYNDROME; SRS	0.039305382	1.9464269166616561
THUMBS, CONGENITAL CLASPED	0.0384757	1.9053405489711024
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0384615	1.9046373561560168
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	1.9046373561560168
MUSCULAR HYPERTONIA, LETHAL	0.0384615	1.9046373561560168
ARTERIES, ANOMALIES OF	0.0384615	1.9046373561560168
PREPAPILLARY VASCULAR LOOPS	0.0384615	1.9046373561560168
WATSON SYNDROME	0.0384615	1.9046373561560168
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	1.9046373561560168
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.0384615	1.9046373561560168
ATROPHODERMA VERMICULATA; AVA	0.0384615	1.9046373561560168
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	1.9046373561560168
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	1.9046373561560168
ACRORENAL-MANDIBULAR SYNDROME	0.0384615	1.9046373561560168
BETHLEM MYOPATHY 1	0.0384615	1.9046373561560168
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	1.9046373561560168
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	1.9046373561560168
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	1.9046373561560168
THUMB DEFORMITY	0.0384615	1.9046373561560168
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0384615	1.9046373561560168
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	1.9046373561560168
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0379433	1.8789757704674699
BLOOD GROUP, DUFFY SYSTEM; FY	0.037414930000000006	1.8528105600655838
MYELOPEROXIDASE DEFICIENCY	0.037414930000000006	1.8528105600655838
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.037414930000000006	1.8528105600655838
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.037414930000000006	1.8528105600655838
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.036517612	1.8083748156679076
INFANTILE LIVER FAILURE SYNDROME 2	0.0361111	1.788244089073113
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.0361111	1.788244089073113
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.0361111	1.788244089073113
PROTOPORPHYRIA, ERYTHROPOIETIC	0.0361093	1.7881549519557074
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.035862002000000004	1.775908601477888
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.035645972	1.765210661770638
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.035427392	1.7543864444803978
SNEDDON SYNDROME	0.03470637	1.7186809874438724
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.034586492	1.7127445544659263
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.034586492	1.7127445544659263
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.034204609999999996	1.6938335207609594
LYSINURIC PROTEIN INTOLERANCE; LPI	0.03400901	1.684147287336259
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.03374261	1.6709549939602868
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0333333	1.6506857086685478
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0333333	1.6506857086685478
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0333333	1.6506857086685478
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.0333333	1.6506857086685478
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0333333	1.6506857086685478
IMMUNE SUPPRESSION	0.0333333	1.6506857086685478
MYASTHENIA GRAVIS; MG	0.0333333	1.6506857086685478
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0333333	1.6506857086685478
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0333333	1.6506857086685478
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0333333	1.6506857086685478
TRICHOHEPATOENTERIC SYNDROME 1	0.0333333	1.6506857086685478
RAGWEED SENSITIVITY	0.0333333	1.6506857086685478
SHORT SYNDROME	0.0333333	1.6506857086685478
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0333333	1.6506857086685478
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0333333	1.6506857086685478
ECHO VIRUS 11 SENSITIVITY	0.0333333	1.6506857086685478
#246300 LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3	0.0333333	1.6506857086685478
#254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL;;LGM;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib; CMS1B;;CMS Ib;;MYASTHENIC MYOPATHY, FORMERLY	0.0333333	1.6506857086685478
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0333333	1.6506857086685478
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0333333	1.6506857086685478
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.033325302	1.650289642743544
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.0329524	1.631823304213188
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.03248142	1.6085000822379043
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.032435982	1.606249964270872
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.032435982	1.606249964270872
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.032166799999999995	1.5929199045278877
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.032098392	1.5895322979015234
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.030690792	1.5198270720906422
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.030069379999999996	1.4890543640900797
GLYCOGEN STORAGE DISEASE VI	0.029979	1.4845786903839222
GLYCOGEN STORAGE DISEASE IXA	0.029979	1.4845786903839222
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.029853782	1.4783778172910074
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.029511002	1.461403138899807
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.029511002	1.461403138899807
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.029415282	1.4566630250786805
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.029415282	1.4566630250786805
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.0285714	1.414873464573041
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0285714	1.414873464573041
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.0285714	1.414873464573041
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.0285714	1.414873464573041
STROKE, ISCHEMIC	0.0285714	1.414873464573041
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0285714	1.414873464573041
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.0285714	1.414873464573041
#605714 CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED;;AMYLOIDOSIS, CEREBROARTERIAL, APP-RELATED;;AMYLOIDOSIS, HEREDITARY, WITH CEREBRAL HEMORRHAGE, DUTCH VARIANT;HCHWAD;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, DUTCH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT	0.0285714	1.414873464573041
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.0285714	1.414873464573041
Polyarteritis nodosa, childhood-onset	0.0285714	1.414873464573041
WOLFF-PARKINSON-WHITE SYNDROME	0.0285714	1.414873464573041
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.0285714	1.414873464573041
WILLIAMS-BEUREN SYNDROME; WBS	0.0285714	1.414873464573041
CARDIOMYOPATHY, DILATED, 1E	0.0285714	1.414873464573041
DERMOGRAPHISM, FAMILIAL	0.0285714	1.414873464573041
AMYLOIDOSIS VI	0.0285714	1.414873464573041
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.0285714	1.414873464573041
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.0285714	1.414873464573041
PSEUDOXANTHOMA ELASTICUM; PXE	0.0285714	1.414873464573041
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.0285714	1.414873464573041
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.0285714	1.414873464573041
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.0285714	1.414873464573041
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.0285714	1.414873464573041
#615745 ATRIAL STANDSTILL 2; ATRST2;;ATRIAL DILATION AND STANDSTILL;;CARDIOMYOPATHY, ATRIAL DILATED, WITH ATRIAL STANDSTILL	0.0285714	1.414873464573041
SICKLE CELL ANEMIA	0.0285714	1.414873464573041
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.0285714	1.414873464573041
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.0277778	1.3755738999214955
GLYCOGEN STORAGE DISEASE IXC	0.02741491	1.3576033618463956
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.026519592	1.3132666586902813
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.026202112	1.2975448520048318
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.026057592	1.2903881318896084
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.026039482000000003	1.2894913134472705
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.025843882000000002	1.2798050800225698
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.025843882000000002	1.2798050800225698
ARGININOSUCCINIC ACIDURIA	0.025843882000000002	1.2798050800225698
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.02535823	1.2557552914991923
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.02535823	1.2557552914991923
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.02521371	1.248598571383969
GLUTARIC ACIDEMIA I; GA1	0.0251956	1.2477017529416308
RIBOFLAVIN DEFICIENCY	0.0251956	1.2477017529416308
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0251956	1.2477017529416308
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.02500287	1.2381576436985708
PATENT DUCTUS VENOSUS	0.025	1.2380155195169305
GLUTAMINE DEFICIENCY, CONGENITAL	0.025	1.2380155195169305
SPLENOPORTAL VASCULAR ANOMALIES	0.025	1.2380155195169305
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.025	1.2380155195169305
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.025	1.2380155195169305
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.024778292	1.227036401724888
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.024778292	1.227036401724888
FUMARASE DEFICIENCY; FMRD	0.024750902	1.2256800319217052
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.024750902	1.2256800319217052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.024534872000000003	1.2149820922144556
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.024369019999999998	1.2067689982167384
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.024369019999999998	1.2067689982167384
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.023937392000000002	1.1853945117104165
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.02390702	1.1838904714160658
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.023690990000000002	1.173192531708816
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.02369099	1.173192531708816
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.02368943	1.1731152795403983
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.02368943	1.1731152795403983
NEPHROSIALIDOSIS	0.02368943	1.1731152795403983
SPINAL ARACHNOIDITIS	0.02368943	1.1731152795403983
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.02368943	1.1731152795403983
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02368943	1.1731152795403983
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.023645552	1.1709424137417836
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.023395992	1.158584047619758
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.023395992	1.158584047619758
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.023395992	1.158584047619758
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.023093509999999998	1.143604951204777
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.023093509999999998	1.143604951204777
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.023093509999999998	1.143604951204777
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.023093509999999998	1.143604951204777
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02294953	1.1364749722247751
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02294953	1.1364749722247751
GRANULOMAS, CONGENITAL CEREBRAL	0.02294953	1.1364749722247751
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02294953	1.1364749722247751
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02294953	1.1364749722247751
#610773 MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY;;MPCD	0.02263151	1.1207264244041042
#557000 PEARSON MARROW-PANCREAS SYNDROME;;SIDEROBLASTIC ANEMIA WITH MARROW CELL VACUOLIZATION AND EXOCRINE PANCREATICDYSFUNCTION	0.02263151	1.1207264244041042
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.02255211	1.1167944871141184
VERVERI-BRADY SYNDROME; VERBRAS	0.02255211	1.1167944871141184
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.022120482	1.0954200006077963
SPINOCEREBELLAR ATAXIA 5; SCA5	0.022120482	1.0954200006077963
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.022120482	1.0954200006077963
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.022120482	1.0954200006077963
PEROXISOME BIOGENESIS DISORDER 6B	0.022120482	1.0954200006077963
HYPERMANGANESEMIA WITH DYSTONIA 2	0.021904252	1.0847121567763902
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.021777502000000004	1.0784354180924398
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.021727192000000003	1.0759440356609637
#117360 SPINOCEREBELLAR ATAXIA 29; SCA29;;CEREBELLAR ATAXIA, CONGENITAL NONPROGRESSIVE, AUTOSOMAL DOMINANT;CNPCA;;CEREBELLAR VERMIS APLASIA;;APLASIA OF CEREBELLAR VERMIS; ACV	0.0212766	1.0536304401021568
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0212766	1.0536304401021568
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0212766	1.0536304401021568
DEMENTIA, FAMILIAL DANISH	0.0212766	1.0536304401021568
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.0212766	1.0536304401021568
SPINOCEREBELLAR ATAXIA 40; SCA40	0.0212766	1.0536304401021568
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0212766	1.0536304401021568
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.0212766	1.0536304401021568
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.0212766	1.0536304401021568
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.0212766	1.0536304401021568
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.0212766	1.0536304401021568
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.0212766	1.0536304401021568
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0212766	1.0536304401021568
EPISODIC ATAXIA, TYPE 8	0.0212766	1.0536304401021568
#613728 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10	0.0212766	1.0536304401021568
MYOCLONUS AND ATAXIA	0.0212766	1.0536304401021568
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0212766	1.0536304401021568
Boucher-Neuhauser syndrome	0.0212766	1.0536304401021568
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0212766	1.0536304401021568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.02106037	1.042922596270751
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.02093362	1.0366458575868
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.020501992000000004	1.0152713710804782
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.020501992000000004	1.0152713710804782
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.020451682000000002	1.012779988649002
BAND HETEROTOPIA; BH	0.020451682000000002	1.012779988649002
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.019850912	0.9830294853025947
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.019711782	0.9761396813333791
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.019711782	0.9761396813333791
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.019711782	0.9761396813333791
ALSTROM SYNDROME; ALMS	0.019711782	0.9761396813333791
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.019675412000000003	0.9743386163555859
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.019675412000000003	0.9743386163555859
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.019675412000000003	0.9743386163555859
MAPLE SYRUP URINE DISEASE; MSUD	0.01965811	0.9734818105748385
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01965811	0.9734818105748385
GLYCOGEN STORAGE DISEASE IA	0.01965811	0.9734818105748385
GLYCOGEN STORAGE DISEASE IB	0.01965811	0.9734818105748385
DOUBLE NAIL FOR FIFTH TOE	0.0196078	0.9709904281433628
PUBIC BONE DYSPLASIA	0.0196078	0.9709904281433628
LETTERER-SIWE DISEASE	0.0196078	0.9709904281433628
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	0.9709904281433628
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	0.9709904281433628
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	0.9709904281433628
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	0.9709904281433628
MEGAEPIPHYSEAL DWARFISM	0.0196078	0.9709904281433628
HHHH SYNDROME	0.0196078	0.9709904281433628
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	0.9709904281433628
RAYNAUD DISEASE	0.0196078	0.9709904281433628
BEEMER LETHAL MALFORMATION SYNDROME	0.0196078	0.9709904281433628
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	0.9709904281433628
THROMBOCYTOPENIA 3	0.0196078	0.9709904281433628
TOE, MISSHAPEN	0.0196078	0.9709904281433628
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	0.9709904281433628
VESICOURETERAL REFLUX 1	0.0196078	0.9709904281433628
MONOPHALANGY OF GREAT TOE	0.0196078	0.9709904281433628
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	0.9709904281433628
THROMBOCYTHEMIA, ESSENTIAL	0.0196078	0.9709904281433628
TRACHEOBRONCHOMEGALY	0.0196078	0.9709904281433628
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	0.9709904281433628
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0196078	0.9709904281433628
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0196078	0.9709904281433628
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	0.9709904281433628
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0196078	0.9709904281433628
CARPAL DISPLACEMENT	0.0196078	0.9709904281433628
KNUCKLE PADS	0.0196078	0.9709904281433628
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	0.9709904281433628
PACHYDERMODACTYLY, FAMILIAL	0.0196078	0.9709904281433628
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	0.9709904281433628
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	0.9709904281433628
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0196078	0.9709904281433628
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	0.9709904281433628
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	0.9709904281433628
THALIDOMIDE SUSCEPTIBILITY	0.0196078	0.9709904281433628
#215300 CHONDROSARCOMA	0.0196078	0.9709904281433628
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	0.9709904281433628
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0196078	0.9709904281433628
VAN DEN BOSCH SYNDROME	0.0196078	0.9709904281433628
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	0.9709904281433628
KOOLEN-DE VRIES SYNDROME; KDVS	0.019360792	0.9587584386455692
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.019360792	0.9587584386455692
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.019360792	0.9587584386455692
ROIFMAN SYNDROME; RFMN	0.019360792	0.9587584386455692
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.019360792	0.9587584386455692
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	0.9343501208277396
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.9343501208277396
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	0.0188679	0.9343501208277396
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.9343501208277396
Lipodystrophy, congenital generalized, type 1	0.0188679	0.9343501208277396
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.0188679	0.9343501208277396
NIEMANN-PICK DISEASE, TYPE B	0.0188679	0.9343501208277396
CARDIAC ARRHYTHMIA	0.0188679	0.9343501208277396
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.9343501208277396
#605814 CITRULLINEMIA, TYPE II, NEONATAL-ONSET;;CHOLESTASIS, NEONATAL INTRAHEPATIC, CAUSED BY CITRIN DEFICIENCY; NICCD	0.0188679	0.9343501208277396
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.9343501208277396
ERYTHERMALGIA, PRIMARY	0.0188679	0.9343501208277396
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.0188679	0.9343501208277396
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	0.9343501208277396
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.9343501208277396
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.9343501208277396
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.0188679	0.9343501208277396
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.0188679	0.9343501208277396
ATHEROSCLEROSIS SUSCEPTIBILITY	0.0188679	0.9343501208277396
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.0188679	0.9343501208277396
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.0188679	0.9343501208277396
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.9343501208277396
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	0.9343501208277396
TEMPLE SYNDROME	0.0188679	0.9343501208277396
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0188679	0.9343501208277396
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.9343501208277396
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.0188679	0.9343501208277396
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.9343501208277396
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.9343501208277396
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.9343501208277396
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.9343501208277396
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.9343501208277396
Lipodystrophy, congenital generalized, type 2	0.0188679	0.9343501208277396
#608898 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3;;HPLH3;;HLH3	0.0188679	0.9343501208277396
CERVICAL RIB	0.0188679	0.9343501208277396
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.9343501208277396
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0188679	0.9343501208277396
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.9343501208277396
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	0.9343501208277396
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	0.9343501208277396
DIASTEMATOMYELIA	0.0188679	0.9343501208277396
#613877 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PLIN1 MUTATIONS	0.0188679	0.9343501208277396
MYOPATHY, CONGENITAL	0.0188679	0.9343501208277396
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.0188679	0.9343501208277396
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.9343501208277396
#613101 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	0.0188679	0.9343501208277396
TRANSSEXUALITY	0.0188679	0.9343501208277396
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	0.9343501208277396
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.0188679	0.9343501208277396
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.0188679	0.9343501208277396
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.9343501208277396
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.0188679	0.9343501208277396
ALCOHOL DEPENDENCE	0.0188679	0.9343501208277396
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0188679	0.9343501208277396
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.0188679	0.9343501208277396
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.9343501208277396
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	0.9343501208277396
269800 SENILE PLAQUE FORMATION	0.0188679	0.9343501208277396
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.0188679	0.9343501208277396
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.9343501208277396
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.9343501208277396
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.0188679	0.9343501208277396
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	0.9343501208277396
MOTION SICKNESS	0.0188679	0.9343501208277396
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.9343501208277396
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.0188679	0.9343501208277396
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.0188679	0.9343501208277396
PALMOMENTAL REFLEX	0.0188679	0.9343501208277396
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0188679	0.9343501208277396
APOLIPOPROTEIN C-II DEFICIENCY	0.0188679	0.9343501208277396
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	0.9343501208277396
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.0188679	0.9343501208277396
#615238 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH CIDEC MUTATIONS	0.0188679	0.9343501208277396
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	0.9343501208277396
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	0.9343501208277396
HYPERLIPOPROTEINEMIA, TYPE IV	0.0188679	0.9343501208277396
JUMPING FRENCHMAN OF MAINE	0.0188679	0.9343501208277396
FISH-EYE DISEASE	0.0188679	0.9343501208277396
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.9343501208277396
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.0188679	0.9343501208277396
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.01883153	0.9325490558499463
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.01883153	0.9325490558499463
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.01883153	0.9325490558499463
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.018786092	0.930298937882914
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.018786092	0.930298937882914
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.01851691	0.9169688781399298
PHENYLKETONURIA	0.01851691	0.9169688781399298
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.01851691	0.9169688781399298
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.01851691	0.9169688781399298
IMMUNODEFICIENCY 55; IMD55	0.01851691	0.9169688781399298
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.01851691	0.9169688781399298
DUBOWITZ SYNDROME	0.01851691	0.9169688781399298
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.018399902000000003	0.9111745693436244
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.018399902000000003	0.9111745693436244
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.018399902000000003	0.9111745693436244
LEIGH SYNDROME; LS	0.018399902000000003	0.9111745693436244
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.018399902000000003	0.9111745693436244
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.018399902000000003	0.9111745693436244
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.018399902000000003	0.9111745693436244
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.018399902000000003	0.9111745693436244
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.018399902000000003	0.9111745693436244
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.018085282	0.8955943916336075
SULFOCYSTEINURIA	0.018085282	0.8955943916336075
PELGER-HUET ANOMALY; PHA	0.018085282	0.8955943916336075
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.018085282	0.8955943916336075
CHROMOSOME 2q37 DELETION SYNDROME	0.018085282	0.8955943916336075
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.01794221	0.8885093773772745
#278250 WRINKLY SKIN SYNDROME; WSS	0.01794221	0.8885093773772745
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.01755602	0.8693850088379846
#614096 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8;;CARDIOMYOPATHY, HYPERTROPHIC MITOCHONDRIAL, FATAL INFANTILE	0.01755602	0.8693850088379846
LIVER FAILURE, INFANTILE, TRANSIENT	0.01755602	0.8693850088379846
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.01755602	0.8693850088379846
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.01755602	0.8693850088379846
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.01755602	0.8693850088379846
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.01755602	0.8693850088379846
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.01755602	0.8693850088379846
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.01755602	0.8693850088379846
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.017510582	0.8671348908709523
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.017510582	0.8671348908709523
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.017510582	0.8671348908709523
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.017510582	0.8671348908709523
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.017510582	0.8671348908709523
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.017510582	0.8671348908709523
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.017510582	0.8671348908709523
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.017510582	0.8671348908709523
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.017510582	0.8671348908709523
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.017510582	0.8671348908709523
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.017510582	0.8671348908709523
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.017510582	0.8671348908709523
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.017510582	0.8671348908709523
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.017510582	0.8671348908709523
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.017510582	0.8671348908709523
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.017510582	0.8671348908709523
PEHO-LIKE SYNDROME; PEHOL	0.017510582	0.8671348908709523
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.017510582	0.8671348908709523
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.017510582	0.8671348908709523
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.017510582	0.8671348908709523
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.017510582	0.8671348908709523
MEIER-GORLIN SYNDROME 7	0.017510582	0.8671348908709523
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.017510582	0.8671348908709523
PEHO SYNDROME; PEHO	0.017510582	0.8671348908709523
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.017510582	0.8671348908709523
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.017510582	0.8671348908709523
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.017510582	0.8671348908709523
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.017510582	0.8671348908709523
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.017510582	0.8671348908709523
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.017510582	0.8671348908709523
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.017263372	0.854892898207761
NEUTROPHIL CHEMOTACTIC RESPONSE	0.0172414	0.8538048311279682
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0172414	0.8538048311279682
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.0172414	0.8538048311279682
#614162 IMMUNODEFICIENCY 31C; IMD31C;;CANDIDIASIS, FAMILIAL, 7; CANDF7;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0172414	0.8538048311279682
#615607 IMMUNODEFICIENCY 17; IMD17;;CD3-GAMMA DEFICIENCY;;SCID-LIKE IMMUNODEFICIENCY, T CELL-PARTIAL, B CELL-POSITIVE, NK CELL-POSITIVE	0.0172414	0.8538048311279682
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.0172414	0.8538048311279682
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0172414	0.8538048311279682
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.0172414	0.8538048311279682
IMMUNODEFICIENCY 50; IMD50	0.0172414	0.8538048311279682
#301000 WISKOTT-ALDRICH SYNDROME; WAS;;WISKOTT-ALDRICH SYNDROME 1; WAS1;;ALDRICH SYNDROME;;ECZEMA-THROMBOCYTOPENIA-IMMUNODEFICIENCY SYNDROME;;IMMUNODEFICIENCY 2; IMD2	0.0172414	0.8538048311279682
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.0172414	0.8538048311279682
CASPASE 8 DEFICIENCY	0.0172414	0.8538048311279682
#103285 ADULT SYNDROME;;ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME	0.0172414	0.8538048311279682
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.0172414	0.8538048311279682
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0172414	0.8538048311279682
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.0172414	0.8538048311279682
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.0172414	0.8538048311279682
BLAU SYNDROME	0.0172414	0.8538048311279682
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.0172414	0.8538048311279682
BAZEX SYNDROME; BZX	0.0172414	0.8538048311279682
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0172414	0.8538048311279682
THROMBOCYTOPENIA 1	0.0172414	0.8538048311279682
#614493 WISKOTT-ALDRICH SYNDROME 2; WAS2;;WIPF1 DEFICIENCY	0.0172414	0.8538048311279682
MYCOSIS FUNGOIDES	0.0172414	0.8538048311279682
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0172414	0.8538048311279682
COFFIN-SIRIS SYNDROME 8; CSS8	0.0172414	0.8538048311279682
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.0172414	0.8538048311279682
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.0172414	0.8538048311279682
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.0172414	0.8538048311279682
PORPHYRIA CUTANEA TARDA, TYPE I	0.0172414	0.8538048311279682
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.0172414	0.8538048311279682
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.0172414	0.8538048311279682
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.017044792	0.8440686809175207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.017044792	0.8440686809175207
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.017044792	0.8440686809175207
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0166667	0.825345330365313
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.0166667	0.825345330365313
Trichothiodystrophy 5, nonphotosensitive	0.0166667	0.825345330365313
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0166667	0.825345330365313
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0166667	0.825345330365313
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.0166667	0.825345330365313
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.0166667	0.825345330365313
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0166667	0.825345330365313
RETT SYNDROME, CONGENITAL VARIANT	0.0166667	0.825345330365313
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.0166667	0.825345330365313
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0166667	0.825345330365313
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.0166667	0.825345330365313
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0166667	0.825345330365313
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.0166667	0.825345330365313
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.016203892	0.8024267909030494
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.016203892	0.8024267909030494
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.015769282	0.7809046339055591
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.015769282	0.7809046339055591
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.015769282	0.7809046339055591
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.015769282	0.7809046339055591
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.015769282	0.7809046339055591
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.015769282	0.7809046339055591
RECOMBINANT CHROMOSOME 8 SYNDROME	0.015769282	0.7809046339055591
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.015769282	0.7809046339055591
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.015769282	0.7809046339055591
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.015769282	0.7809046339055591
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.015769282	0.7809046339055591
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.015769282	0.7809046339055591
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.015769282	0.7809046339055591
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.015769282	0.7809046339055591
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.015769282	0.7809046339055591
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.015769282	0.7809046339055591
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.015769282	0.7809046339055591
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.015769282	0.7809046339055591
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.015769282	0.7809046339055591
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.015769282	0.7809046339055591
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.015769282	0.7809046339055591
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.015769282	0.7809046339055591
MENTAL RETARDATION, X-LINKED 98; MRX98	0.015769282	0.7809046339055591
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.015769282	0.7809046339055591
LISSENCEPHALY 1; LIS1	0.015769282	0.7809046339055591
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.015769282	0.7809046339055591
WEBB-DATTANI SYNDROME; WEDAS	0.015769282	0.7809046339055591
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015769282	0.7809046339055591
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.015769282	0.7809046339055591
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.015525862000000001	0.7688503243951267
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.01514398	0.7499392906901601
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014928382	0.7392627438910877
HYDROXYKYNURENINURIA	0.014928382	0.7392627438910877
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.014928382	0.7392627438910877
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.014928382	0.7392627438910877
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.014925399999999998	0.7391150733999197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.014925399999999998	0.7391150733999197
WARBURG MICRO SYNDROME 2; WARBM2	0.014925399999999998	0.7391150733999197
RETT SYNDROME; RTT	0.014925399999999998	0.7391150733999197
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.014925399999999998	0.7391150733999197
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.014925399999999998	0.7391150733999197
WARBURG MICRO SYNDROME 3; WARBM3	0.014925399999999998	0.7391150733999197
MENTAL RETARDATION, X-LINKED 1	0.014925399999999998	0.7391150733999197
PALLISTER-KILLIAN SYNDROME	0.014925399999999998	0.7391150733999197
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.014925399999999998	0.7391150733999197
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.014925399999999998	0.7391150733999197
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.014925399999999998	0.7391150733999197
BARAITSER-WINTER SYNDROME 2; BRWS2	0.014925399999999998	0.7391150733999197
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.014925399999999998	0.7391150733999197
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.014925399999999998	0.7391150733999197
SUDDEN CARDIAC FAILURE, INFANTILE	0.0140845	0.6974731833854482
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.0140845	0.6974731833854482
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.0140845	0.6974731833854482
#613677 HYPERALDOSTERONISM, FAMILIAL, TYPE III;;FH III	0.0140845	0.6974731833854482
HAWKINSINURIA	0.0140845	0.6974731833854482
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.0140845	0.6974731833854482
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.0140845	0.6974731833854482
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0140845	0.6974731833854482
LACTASE DEFICIENCY, CONGENITAL	0.0140845	0.6974731833854482
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.0140845	0.6974731833854482
#615605 FANCONI RENOTUBULAR SYNDROME 3; FRTS3	0.0140845	0.6974731833854482
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.0140845	0.6974731833854482
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.0140845	0.6974731833854482
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.0140845	0.6974731833854482
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.013230492000000002	0.6551821770737838
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.013230492000000002	0.6551821770737838
MEHMO SYNDROME; MEHMO	0.013230492000000002	0.6551821770737838
HOLOPROSENCEPHALY 1; HPE1	0.013230492000000002	0.6551821770737838
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.012386610000000001	0.6133926165681443
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.011954982000000001	0.5920181300618221
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.011954982000000001	0.5920181300618221
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.011954982000000001	0.5920181300618221
COSTELLO SYNDROME; CSTLO	0.011954982000000001	0.5920181300618221
MIRAGE SYNDROME; MIRAGE	0.011954982000000001	0.5920181300618221
TIMOTHY SYNDROME; TS	0.011954982000000001	0.5920181300618221
SHASHI-PENA SYNDROME; SHAPNS	0.011954982000000001	0.5920181300618221
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.011954982000000001	0.5920181300618221
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.011128402	0.5510853753369299
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.011128402	0.5510853753369299
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.011128401999999999	0.5510853753369298
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.0111111	0.5502285695561826
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.0111111	0.5502285695561826
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.0111111	0.5502285695561826
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.0111111	0.5502285695561826
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.0111111	0.5502285695561826
HEMOCHROMATOSIS, NEONATAL	0.0111111	0.5502285695561826
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.0111111	0.5502285695561826
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.0111111	0.5502285695561826
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.0111111	0.5502285695561826
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0111111	0.5502285695561826
TENORIO SYNDROME; TNORS	0.0111111	0.5502285695561826
#609016 LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY;;LCHAD DEFICIENCY	0.0111111	0.5502285695561826
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.0111111	0.5502285695561826
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.0111111	0.5502285695561826
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.0111111	0.5502285695561826
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.0111111	0.5502285695561826
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.0111111	0.5502285695561826
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0111111	0.5502285695561826
FRUCTOSE AND GALACTOSE INTOLERANCE	0.0111111	0.5502285695561826
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.0111111	0.5502285695561826
SMITH-KINGSMORE SYNDROME; SKS	0.0111111	0.5502285695561826
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.0111111	0.5502285695561826
TYROSINEMIA, TYPE I; TYRSN1	0.0111111	0.5502285695561826
VISCERAL STEATOSIS, CONGENITAL	0.0111111	0.5502285695561826
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.010666402000000002	0.528206848536257
INFANTILE LIVER FAILURE SYNDROME 1	0.010666402000000002	0.528206848536257
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.010666402000000002	0.528206848536257
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.010666402000000002	0.528206848536257
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.01028452	0.5092958148312904
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.0102166	0.5059323742678667
MYOPATHY, SPHEROID BODY	0.0102166	0.5059323742678667
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.0102166	0.5059323742678667
PERRY SYNDROME	0.0102166	0.5059323742678667
GLUTATHIONURIA	0.0102166	0.5059323742678667
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.009852892	0.48792132832496826
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.009852892	0.48792132832496826
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.009852892	0.48792132832496826
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.009852892	0.48792132832496826
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.009852892	0.48792132832496826
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.009852892	0.48792132832496826
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.009852892	0.48792132832496826
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.009852892	0.48792132832496826
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.009852892	0.48792132832496826
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.009852892	0.48792132832496826
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.009852892	0.48792132832496826
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.009852892	0.48792132832496826
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.009852892	0.48792132832496826
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.009852892	0.48792132832496826
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.009852892	0.48792132832496826
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009852892	0.48792132832496826
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.009822520000000001	0.4864172880306176
PSEUDO-TORCH SYNDROME 2	0.009822520000000001	0.4864172880306176
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.009822520000000001	0.4864172880306176
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.009390892000000001	0.46504280152429545
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.009390892000000001	0.46504280152429545
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.009390892000000001	0.46504280152429545
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.009390892000000001	0.46504280152429545
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.009390892000000001	0.46504280152429545
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.009390892000000001	0.46504280152429545
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.009390892000000001	0.46504280152429545
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.009390892000000001	0.46504280152429545
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.009390892000000001	0.46504280152429545
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.009390892000000001	0.46504280152429545
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.009390892000000001	0.46504280152429545
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00900901	0.44613176781932884
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00900901	0.44613176781932884
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00900901	0.44613176781932884
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00900901	0.44613176781932884
#615395 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16	0.00900901	0.44613176781932884
PERRAULT SYNDROME 5; PRLTS5	0.00900901	0.44613176781932884
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00900901	0.44613176781932884
LEBER OPTIC ATROPHY AND DYSTONIA	0.00900901	0.44613176781932884
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00900901	0.44613176781932884
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00900901	0.44613176781932884
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00900901	0.44613176781932884
#614651 COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	0.00900901	0.44613176781932884
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00900901	0.44613176781932884
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00900901	0.44613176781932884
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00900901	0.44613176781932884
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00900901	0.44613176781932884
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.00900901	0.44613176781932884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00900901	0.44613176781932884
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00854701	0.42325324101865597
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00854701	0.42325324101865597
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00854701	0.42325324101865597
#615595 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19	0.00854701	0.42325324101865597
#614111 PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	0.00854701	0.42325324101865597
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00854701	0.42325324101865597
PHENFORMIN 4-HYDROXYLATION	0.00854701	0.42325324101865597
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00854701	0.42325324101865597
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.00854701	0.42325324101865597
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00854701	0.42325324101865597
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00854701	0.42325324101865597
#614053 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3;MC5DN3;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5E TYPE	0.00854701	0.42325324101865597
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00854701	0.42325324101865597
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00854701	0.42325324101865597
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 4; CEMCOX4	0.00854701	0.42325324101865597
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00854701	0.42325324101865597
SUCCINIC ACIDEMIA	0.00854701	0.42325324101865597
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.00854701	0.42325324101865597
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00854701	0.42325324101865597
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.008254362000000001	0.40876113038843237
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.008254362000000001	0.40876113038843237
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.008254362000000001	0.40876113038843237
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.008254362000000001	0.40876113038843237
JABERI-ELAHI SYNDROME; JABELS	0.008254362000000001	0.40876113038843237
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.008254362000000001	0.40876113038843237
TONNE-KALSCHEUER SYNDROME; TOKAS	0.008254362000000001	0.40876113038843237
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.008254362000000001	0.40876113038843237
AICARDI-GOUTIERES SYNDROME 6	0.008254362000000001	0.40876113038843237
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.008254362000000001	0.40876113038843237
COCKAYNE SYNDROME A; CSA	0.0074104800000000005	0.3669715698827929
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.0074104800000000005	0.3669715698827929
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.0074104800000000005	0.3669715698827929
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0074104800000000005	0.3669715698827929
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0074104800000000005	0.3669715698827929
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0074104800000000005	0.3669715698827929
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0074104800000000005	0.3669715698827929
CHROMOSOME 18Q DELETION SYNDROME	0.0074104800000000005	0.3669715698827929
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.006978852	0.3455970833764707
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.006978852	0.3455970833764707
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.006978852	0.3455970833764707
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.006978852	0.3455970833764707
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.006978852	0.3455970833764707
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.006978852	0.3455970833764707
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.006978852	0.3455970833764707
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.006978852	0.3455970833764707
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.006978852	0.3455970833764707
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.006978852	0.3455970833764707
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.006978852	0.3455970833764707
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.006978852	0.3455970833764707
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.006978852	0.3455970833764707
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.006978852	0.3455970833764707
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.006978852	0.3455970833764707
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.006978852	0.3455970833764707
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.006978852	0.3455970833764707
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.006978852	0.3455970833764707
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.006978852	0.3455970833764707
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.006978852	0.3455970833764707
GABRIELE-DE VRIES SYNDROME; GADEVS	0.006978852	0.3455970833764707
PEROXISOME BIOGENESIS DISORDER 5B	0.006978852	0.3455970833764707
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.006978852	0.3455970833764707
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.006978852	0.3455970833764707
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.006978852	0.3455970833764707
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.006978852	0.3455970833764707
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.006978852	0.3455970833764707
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.006978852	0.3455970833764707
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.006978852	0.3455970833764707
MENTAL RETARDATION, X-LINKED 104; MRX104	0.006978852	0.3455970833764707
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.0062010220000000005	0.3070784589146366
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.0062010220000000005	0.3070784589146366
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0062010220000000005	0.3070784589146366
EMANUEL SYNDROME	0.0062010220000000005	0.3070784589146366
CHROMOSOME 10Q26 DELETION SYNDROME	0.0062010220000000005	0.3070784589146366
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.0062010220000000005	0.3070784589146366
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.006201022	0.30707845891463653
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.00613497	0.3038075228708313
SPINOCEREBELLAR ATAXIA 18	0.00613497	0.3038075228708313
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00613497	0.3038075228708313
#605355 NEMALINE MYOPATHY 5; NEM5;;NEMALINE MYOPATHY, AMISH TYPE; ANM;;AMISH NEMALINE MYOPATHY	0.00613497	0.3038075228708313
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.00613497	0.3038075228708313
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.00613497	0.3038075228708313
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.00613497	0.3038075228708313
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00613497	0.3038075228708313
SPINOCEREBELLAR ATAXIA 42	0.00613497	0.3038075228708313
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00613497	0.3038075228708313
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00613497	0.3038075228708313
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00613497	0.3038075228708313
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00613497	0.3038075228708313
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00613497	0.3038075228708313
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.00613497	0.3038075228708313
MYOCLONIC-ATONIC EPILEPSY	0.00613497	0.3038075228708313
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.00613497	0.3038075228708313
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00613497	0.3038075228708313
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00613497	0.3038075228708313
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00613497	0.3038075228708313
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00613497	0.3038075228708313
EPISODIC ATAXIA, TYPE 1; EA1	0.00613497	0.3038075228708313
CEREBELLAR HYPOPLASIA	0.00613497	0.3038075228708313
DYSTONIA 11, MYOCLONIC	0.00613497	0.3038075228708313
KUFOR-RAKEB SYNDROME	0.00613497	0.3038075228708313
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.00613497	0.3038075228708313
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.00613497	0.3038075228708313
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.00613497	0.3038075228708313
#600116 PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2;;PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ;;PARKINSONISM, EARLY-ONSET, WITH DIURNAL FLUCTUATION; EPDF	0.00613497	0.3038075228708313
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00613497	0.3038075228708313
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00613497	0.3038075228708313
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00613497	0.3038075228708313
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00613497	0.3038075228708313
#158580 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A;;HMN VIIA;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA;;DHMN7A;;DHMNVP;;SPINAL MUSCULAR ATROPHY, DISTAL, WITH VOCAL CORD PARALYSIS;;HARPER-YOUNG MYOPATHY	0.00613497	0.3038075228708313
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.00613497	0.3038075228708313
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00613497	0.3038075228708313
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.00613497	0.3038075228708313
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.00613497	0.3038075228708313
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00613497	0.3038075228708313
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00613497	0.3038075228708313
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.00613497	0.3038075228708313
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.00613497	0.3038075228708313
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00613497	0.3038075228708313
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.00613497	0.3038075228708313
#137440 GERSTMANN-STRAUSSLER DISEASE; GSD;;ENCEPHALOPATHY, SUBACUTE SPONGIFORM, GERSTMANN-STRAUSSLER TYPE;;GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GSS;;CEREBELLAR ATAXIA, PROGRESSIVE DEMENTIA, AND AMYLOID DEPOSITS IN CNS;;AMYLOIDOSIS, CEREBRAL, WITH SPONGIFORM ENCEPHALOPATHY;;PRION DEMENTIACEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED, INCLUDED	0.00613497	0.3038075228708313
#276880 UROCANASE DEFICIENCY	0.00613497	0.3038075228708313
#605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE;;PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;;DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;;TYROSINE HYDROXYLASE DEFICIENCY	0.00613497	0.3038075228708313
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00613497	0.3038075228708313
#613227 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME3; CAMRQ3;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 3	0.00613497	0.3038075228708313
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.00613497	0.3038075228708313
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00613497	0.3038075228708313
SPASTIC PARAPARESIS AND DEAFNESS	0.00613497	0.3038075228708313
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.00613497	0.3038075228708313
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.00613497	0.3038075228708313
#608768 SPINOCEREBELLAR ATAXIA 8; SCA8	0.00613497	0.3038075228708313
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.00613497	0.3038075228708313
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.00613497	0.3038075228708313
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00613497	0.3038075228708313
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.00613497	0.3038075228708313
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00613497	0.3038075228708313
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00613497	0.3038075228708313
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00613497	0.3038075228708313
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00613497	0.3038075228708313
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00613497	0.3038075228708313
OPTIC ATROPHY 2	0.00613497	0.3038075228708313
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.00613497	0.3038075228708313
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00613497	0.3038075228708313
#610297 PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK13	0.00613497	0.3038075228708313
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00613497	0.3038075228708313
WILSON DISEASE	0.00613497	0.3038075228708313
DYSTONIA 13, TORSION	0.00613497	0.3038075228708313
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00613497	0.3038075228708313
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.00613497	0.3038075228708313
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00613497	0.3038075228708313
PARKINSON DISEASE 21; PARK21	0.00613497	0.3038075228708313
DYSTONIA 3, TORSION, X-LINKED	0.00613497	0.3038075228708313
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.00613497	0.3038075228708313
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00613497	0.3038075228708313
#176500 CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1;;DEMENTIA, FAMILIAL BRITISH; FBD;;PRESENILE DEMENTIA WITH SPASTIC ATAXIA;;CEREBRAL AMYLOID ANGIOPATHY, BRITISH TYPE	0.00613497	0.3038075228708313
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.00613497	0.3038075228708313
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00613497	0.3038075228708313
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00613497	0.3038075228708313
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.00613497	0.3038075228708313
BEHR SYNDROME	0.00613497	0.3038075228708313
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00613497	0.3038075228708313
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00535714	0.2652888984089971
CARDIAC LIPIDOSIS, FAMILIAL	0.00535714	0.2652888984089971
ASPARTYLGLUCOSAMINURIA; AGU	0.00535714	0.2652888984089971
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00535714	0.2652888984089971
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.00535714	0.2652888984089971
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00535714	0.2652888984089971
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.00535714	0.2652888984089971
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.00535714	0.2652888984089971
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.00535714	0.2652888984089971
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00535714	0.2652888984089971
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00535714	0.2652888984089971
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00535714	0.2652888984089971
XYLOSIDASE DEFICIENCY	0.00535714	0.2652888984089971
REVESZ SYNDROME	0.004925512	0.24391441190267496
EPILEPSY, PYRIDOXINE-DEPENDENT	0.004925512	0.24391441190267496
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004925512	0.24391441190267496
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004925512	0.24391441190267496
#170100 PROLIDASE DEFICIENCY	0.004925512	0.24391441190267496
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004925512	0.24391441190267496
SALLA DISEASE	0.004925512	0.24391441190267496
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.004925512	0.24391441190267496
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004925512	0.24391441190267496
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.004925512	0.24391441190267496
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004925512	0.24391441190267496
LARSEN-LIKE SYNDROME	0.004925512	0.24391441190267496
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00408163	0.2021248513970355
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00408163	0.2021248513970355
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00408163	0.2021248513970355
CHOROIDAL OSTEOMA, BILATERAL	0.00408163	0.2021248513970355
PROGESTERONE RESISTANCE	0.00408163	0.2021248513970355
CONE-ROD DYSTROPHY 1; CORD1	0.00408163	0.2021248513970355
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00408163	0.2021248513970355
XM SYSTEM	0.00408163	0.2021248513970355
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00408163	0.2021248513970355
SCHIZOPHRENIA 4	0.00408163	0.2021248513970355
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00408163	0.2021248513970355
#192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	0.00408163	0.2021248513970355
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00408163	0.2021248513970355
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00408163	0.2021248513970355
DELETED IN AZOOSPERMIA	0.00408163	0.2021248513970355
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00408163	0.2021248513970355
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00408163	0.2021248513970355
LYMPHOKINE DEFICIENCY	0.00408163	0.2021248513970355
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00408163	0.2021248513970355
FINGERPRINT BODY MYOPATHY	0.00408163	0.2021248513970355
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00408163	0.2021248513970355
EPILEPSY-TELANGIECTASIA	0.00408163	0.2021248513970355
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00408163	0.2021248513970355
MAGNESIUM, ELEVATED RED CELL	0.00408163	0.2021248513970355
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00408163	0.2021248513970355
OCULORENOCEREBELLAR SYNDROME	0.00408163	0.2021248513970355
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.00408163	0.2021248513970355
CARBOXYLESTERASE 1	0.00408163	0.2021248513970355
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00408163	0.2021248513970355
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00408163	0.2021248513970355
HYPOASCORBEMIA	0.00408163	0.2021248513970355
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00408163	0.2021248513970355
URATE-BINDING GLOBULIN, DECREASE IN	0.00408163	0.2021248513970355
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00408163	0.2021248513970355
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00408163	0.2021248513970355
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00408163	0.2021248513970355
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00408163	0.2021248513970355
APOLIPOPROTEIN(A)	0.00408163	0.2021248513970355
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00408163	0.2021248513970355
HYPERPROGLUCAGONEMIA	0.00408163	0.2021248513970355
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00408163	0.2021248513970355
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00408163	0.2021248513970355
FLOOD FACTOR DEFICIENCY	0.00408163	0.2021248513970355
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00408163	0.2021248513970355
BEETURIA	0.00408163	0.2021248513970355
GLOMUVENOUS MALFORMATIONS	0.00408163	0.2021248513970355
#270960 SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARRESTPREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 4; RPRGL4	0.00408163	0.2021248513970355
FETAL IODINE DEFICIENCY DISORDER	0.00408163	0.2021248513970355
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00408163	0.2021248513970355
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00408163	0.2021248513970355
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00408163	0.2021248513970355
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00408163	0.2021248513970355
GAPO SYNDROME; GAPOS	0.00408163	0.2021248513970355
PREMATURE OVARIAN FAILURE 1	0.00408163	0.2021248513970355
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00408163	0.2021248513970355
XANTHINURIA, TYPE I	0.00408163	0.2021248513970355
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00408163	0.2021248513970355
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00408163	0.2021248513970355
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00408163	0.2021248513970355
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00408163	0.2021248513970355
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00408163	0.2021248513970355
257960 OCULOTRICHODYSPLASIA; OTD	0.00408163	0.2021248513970355
PREMATURE CENTROMERE DIVISION; PCD	0.00408163	0.2021248513970355
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00408163	0.2021248513970355
ZINC, ELEVATED PLASMA	0.00408163	0.2021248513970355
EHLERS-DANLOS SYNDROME, TYPE VI	0.00408163	0.2021248513970355
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00408163	0.2021248513970355
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00408163	0.2021248513970355
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00408163	0.2021248513970355
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00408163	0.2021248513970355
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00408163	0.2021248513970355
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00408163	0.2021248513970355
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.00408163	0.2021248513970355
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00408163	0.2021248513970355
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00408163	0.2021248513970355
DERMATOLEUKODYSTROPHY	0.00408163	0.2021248513970355
NORMOKALEMIC PERIODIC PARALYSIS	0.00408163	0.2021248513970355
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00408163	0.2021248513970355
OVARIAN CANCER	0.00408163	0.2021248513970355
GLUTATHIONE REDUCTASE	0.00408163	0.2021248513970355
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00408163	0.2021248513970355
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00408163	0.2021248513970355
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00408163	0.2021248513970355
KERATOSIS, FAMILIAL ACTINIC	0.00408163	0.2021248513970355
PYGMY	0.00408163	0.2021248513970355
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00408163	0.2021248513970355
MACROCYTOSIS, FAMILIAL	0.00408163	0.2021248513970355
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00408163	0.2021248513970355
PENDRED SYNDROME	0.00408163	0.2021248513970355
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00408163	0.2021248513970355
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00408163	0.2021248513970355
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00408163	0.2021248513970355
ALAND ISLAND EYE DISEASE	0.00408163	0.2021248513970355
SERTOLI CELL-ONLY SYNDROME	0.00408163	0.2021248513970355
LACTOSE INTOLERANCE, ADULT TYPE	0.00408163	0.2021248513970355
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00408163	0.2021248513970355
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.00408163	0.2021248513970355
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00408163	0.2021248513970355
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00408163	0.2021248513970355
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00408163	0.2021248513970355
HYPERLEUCINE-ISOLEUCINEMIA	0.00408163	0.2021248513970355
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00408163	0.2021248513970355
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00408163	0.2021248513970355
COUMARIN RESISTANCE	0.00408163	0.2021248513970355
AREDYLD	0.00408163	0.2021248513970355
CATECHOL-O-METHYLTRANSFERASE	0.00408163	0.2021248513970355
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00408163	0.2021248513970355
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00408163	0.2021248513970355
CEPHALIN LIPIDOSIS	0.00408163	0.2021248513970355
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00408163	0.2021248513970355
HOOFT DISEASE	0.00408163	0.2021248513970355
TESTICULAR GERM CELL TUMOR; TGCT	0.00408163	0.2021248513970355
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00408163	0.2021248513970355
ALKAPTONURIA	0.00408163	0.2021248513970355
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00408163	0.2021248513970355
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00408163	0.2021248513970355
%608572 BURN-MCKEOWN SYNDROME	0.00408163	0.2021248513970355
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00408163	0.2021248513970355
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00408163	0.2021248513970355
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.00408163	0.2021248513970355
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00408163	0.2021248513970355
PARAOXONASE 1	0.00408163	0.2021248513970355
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.00408163	0.2021248513970355
PROPERDIN DEFICIENCY, X-LINKED	0.00408163	0.2021248513970355
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00408163	0.2021248513970355
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00408163	0.2021248513970355
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00408163	0.2021248513970355
ICHTHYOSIS AND MALE HYPOGONADISM	0.00408163	0.2021248513970355
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00408163	0.2021248513970355
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00408163	0.2021248513970355
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.00408163	0.2021248513970355
LUTHERAN SUPPRESSOR, X-LINKED	0.00408163	0.2021248513970355
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00408163	0.2021248513970355
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00408163	0.2021248513970355
NEUTROPHIL ACTIN DYSFUNCTION	0.00408163	0.2021248513970355
CITRULLINE TRANSPORT DEFECT	0.00408163	0.2021248513970355
TRISOMY 18-LIKE SYNDROME	0.00408163	0.2021248513970355
ETHANOLAMINOSIS	0.00408163	0.2021248513970355
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00408163	0.2021248513970355
HEINZ BODY ANEMIAS	0.00408163	0.2021248513970355
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00408163	0.2021248513970355
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00408163	0.2021248513970355
ONCOCYTOMA	0.00408163	0.2021248513970355
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00408163	0.2021248513970355
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00408163	0.2021248513970355
LIPASE DEFICIENCY, COMBINED	0.00408163	0.2021248513970355
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00408163	0.2021248513970355
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00408163	0.2021248513970355
PACMAN DYSPLASIA	0.00408163	0.2021248513970355
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00408163	0.2021248513970355
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00408163	0.2021248513970355
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00408163	0.2021248513970355
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00408163	0.2021248513970355
GONADOBLASTOMA	0.00408163	0.2021248513970355
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00408163	0.2021248513970355
POLYCYSTIC OVARY SYNDROME 1	0.00408163	0.2021248513970355
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00408163	0.2021248513970355
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00408163	0.2021248513970355
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00408163	0.2021248513970355
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00408163	0.2021248513970355
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00408163	0.2021248513970355
SPERMATOGENIC FAILURE 1; SPGF1	0.00408163	0.2021248513970355
PITUITARY DWARFISM IV	0.00408163	0.2021248513970355
#301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED	0.00408163	0.2021248513970355
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00408163	0.2021248513970355
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00408163	0.2021248513970355
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00408163	0.2021248513970355
CEREBELLOPARENCHYMAL DISORDER V	0.00408163	0.2021248513970355
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00408163	0.2021248513970355
ACETYLATION, SLOW	0.00408163	0.2021248513970355
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00408163	0.2021248513970355
WHITE SPONGE NEVUS OF CANNON	0.00408163	0.2021248513970355
MACULAR DYSTROPHY, CORNEAL, 1	0.00408163	0.2021248513970355
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00408163	0.2021248513970355
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00408163	0.2021248513970355
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00408163	0.2021248513970355
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00408163	0.2021248513970355
CALVARIAL HYPEROSTOSIS	0.00408163	0.2021248513970355
ICHTHYOSIS, X-LINKED	0.00408163	0.2021248513970355
LARON SYNDROME	0.00408163	0.2021248513970355
OSTEOGENIC SARCOMA	0.00408163	0.2021248513970355
T-SUBSTANCE ANOMALY	0.00408163	0.2021248513970355
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00408163	0.2021248513970355
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00408163	0.2021248513970355
OSTEOGENESIS IMPERFECTA, TYPE V	0.00408163	0.2021248513970355
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00408163	0.2021248513970355
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00408163	0.2021248513970355
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.0021193920000000003	0.10495360751760106
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0021193920000000003	0.10495360751760106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.0021193920000000003	0.10495360751760106
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.0021193920000000003	0.10495360751760106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0021193920000000003	0.10495360751760106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0021193920000000003	0.10495360751760106
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.0021193920000000003	0.10495360751760106
GLASS SYNDROME	0.0021193920000000003	0.10495360751760106
SECKEL SYNDROME 8; SCKL8	0.0021193920000000003	0.10495360751760106
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.0021193920000000003	0.10495360751760106
CHROMOSOME 16p13.3 DELETION SYNDROME	0.0021193920000000003	0.10495360751760106
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.0021193920000000003	0.10495360751760106
HARTSFIELD SYNDROME; HRTFDS	0.0021193920000000003	0.10495360751760106
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0021193920000000003	0.10495360751760106
MUCOLIPIDOSIS IV; ML4	0.0021193920000000003	0.10495360751760106
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, X-LINKED 106; MRX106	0.0021193920000000003	0.10495360751760106
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.0021193920000000003	0.10495360751760106
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0021193920000000003	0.10495360751760106
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0021193920000000003	0.10495360751760106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.0021193920000000003	0.10495360751760106
WARSAW BREAKAGE SYNDROME; WABS	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.0021193920000000003	0.10495360751760106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.0021193920000000003	0.10495360751760106
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0021193920000000003	0.10495360751760106
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0021193920000000003	0.10495360751760106
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0021193920000000003	0.10495360751760106
LISSENCEPHALY 2; LIS2	0.0021193920000000003	0.10495360751760106
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0021193920000000003	0.10495360751760106
%300712 CRANIOFACIOSKELETAL SYNDROME	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.0021193920000000003	0.10495360751760106
ALAZAMI SYNDROME; ALAZS	0.0021193920000000003	0.10495360751760106
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.0021193920000000003	0.10495360751760106
KABUKI SYNDROME 1	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0021193920000000003	0.10495360751760106
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0021193920000000003	0.10495360751760106
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.0021193920000000003	0.10495360751760106
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0021193920000000003	0.10495360751760106
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0021193920000000003	0.10495360751760106
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.0021193920000000003	0.10495360751760106
CEREBELLOFACIODENTAL SYNDROME	0.0021193920000000003	0.10495360751760106
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.0021193920000000003	0.10495360751760106
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021193920000000003	0.10495360751760106
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.0021193920000000003	0.10495360751760106
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0021193920000000003	0.10495360751760106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.0021193920000000003	0.10495360751760106
KBG SYNDROME	0.0021193920000000003	0.10495360751760106
MICROPHTHALMIA, SYNDROMIC 3	0.0021193920000000003	0.10495360751760106
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0021193920000000003	0.10495360751760106
ADENYLOSUCCINASE DEFICIENCY	0.0021193920000000003	0.10495360751760106
HOLOPROSENCEPHALY 3; HPE3	0.0021193920000000003	0.10495360751760106
GOLDBERG-SHPRINTZEN SYNDROME	0.0021193920000000003	0.10495360751760106
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.0021193920000000003	0.10495360751760106
CRANIOSYNOSTOSIS 6; CRS6	0.0021193920000000003	0.10495360751760106
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0021193920000000003	0.10495360751760106
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.0021193920000000003	0.10495360751760106
OROFACIODIGITAL SYNDROME XIV; OFD14	0.0021193920000000003	0.10495360751760106
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0021193920000000003	0.10495360751760106
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.0021193920000000003	0.10495360751760106
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.0021193920000000003	0.10495360751760106
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021193920000000003	0.10495360751760106
C SYNDROME	0.0021193920000000003	0.10495360751760106
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.0021193920000000003	0.10495360751760106
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.0021193920000000003	0.10495360751760106
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.0021193920000000003	0.10495360751760106
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0021193920000000003	0.10495360751760106
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.0021193920000000003	0.10495360751760106
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0021193920000000003	0.10495360751760106
WIEACKER-WOLFF SYNDROME	0.0021193920000000003	0.10495360751760106
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0021193920000000003	0.10495360751760106
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.0021193920000000003	0.10495360751760106
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.0021193920000000003	0.10495360751760106
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.0021193920000000003	0.10495360751760106
OROFACIODIGITAL SYNDROME IX; OFD9	0.0021193920000000003	0.10495360751760106
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.0021193920000000003	0.10495360751760106
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.0021193920000000003	0.10495360751760106
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0021193920000000003	0.10495360751760106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.0021193920000000003	0.10495360751760106
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.0021193920000000003	0.10495360751760106
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0021193920000000003	0.10495360751760106
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0021193920000000003	0.10495360751760106
COFFIN-SIRIS SYNDROME 3; CSS3	0.0021193920000000003	0.10495360751760106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.0021193920000000003	0.10495360751760106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.0021193920000000003	0.10495360751760106
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0021193920000000003	0.10495360751760106
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.0021193920000000003	0.10495360751760106
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0021193920000000003	0.10495360751760106
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0021193920000000003	0.10495360751760106
ADAMS-OLIVER SYNDROME 2; AOS2	0.0021193920000000003	0.10495360751760106
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.0021193920000000003	0.10495360751760106
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0021193920000000003	0.10495360751760106
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0021193920000000003	0.10495360751760106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0021193920000000003	0.10495360751760106
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0021193920000000003	0.10495360751760106
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.0021193920000000003	0.10495360751760106
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0021193920000000003	0.10495360751760106
RAINE SYNDROME	0.0021193920000000003	0.10495360751760106
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0021193920000000003	0.10495360751760106
AICARDI-GOUTIERES SYNDROME 5	0.0021193920000000003	0.10495360751760106
OGDEN SYNDROME; OGDNS	0.0021193920000000003	0.10495360751760106
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0021193920000000003	0.10495360751760106
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.0021193920000000003	0.10495360751760106
Glycosylphosphatidylinositol biosynthesis defect 18	0.0021193920000000003	0.10495360751760106
TURNPENNY-FRY SYNDROME; TPFS	0.0021193920000000003	0.10495360751760106
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0021193920000000003	0.10495360751760106
COFFIN-SIRIS SYNDROME 4; CSS4	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.0021193920000000003	0.10495360751760106
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.0021193920000000003	0.10495360751760106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0021193920000000003	0.10495360751760106
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0021193920000000003	0.10495360751760106
BOHRING-OPITZ SYNDROME	0.0021193920000000003	0.10495360751760106
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0021193920000000003	0.10495360751760106
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0021193920000000003	0.10495360751760106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.0021193920000000003	0.10495360751760106
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0021193920000000003	0.10495360751760106
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.0021193920000000003	0.10495360751760106
TOWNES-BROCKS SYNDROME 1; TBS1	0.0021193920000000003	0.10495360751760106
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.0021193920000000003	0.10495360751760106
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.0021193920000000003	0.10495360751760106
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0021193920000000003	0.10495360751760106
COFFIN-SIRIS SYNDROME 5	0.0021193920000000003	0.10495360751760106
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.0021193920000000003	0.10495360751760106
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.0021193920000000003	0.10495360751760106
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0021193920000000003	0.10495360751760106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.0021193920000000003	0.10495360751760106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0021193920000000003	0.10495360751760106
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.10495360751760106
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.0021193920000000003	0.10495360751760106
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.0021193920000000003	0.10495360751760106
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0021193920000000003	0.10495360751760106
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0021193920000000003	0.10495360751760106
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.0021193920000000003	0.10495360751760106
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021193920000000003	0.10495360751760106
LOWRY-MACLEAN SYNDROME	0.0021193920000000003	0.10495360751760106
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0021193920000000003	0.10495360751760106
PHELAN-MCDERMID SYNDROME; PHMDS	0.0021193920000000003	0.10495360751760106
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0021193920000000003	0.10495360751760106
#614728 SECKEL SYNDROME 6; SCKL6	0.0021193920000000003	0.10495360751760106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.0021193920000000003	0.10495360751760106
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0021193920000000003	0.10495360751760106
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0021193920000000003	0.10495360751760106
#602398 DESMOSTEROLOSIS	0.0021193920000000003	0.10495360751760106
MARINESCO-SJOGREN SYNDROME; MSS	0.0021193920000000003	0.10495360751760106
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.0021193920000000003	0.10495360751760106
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0021193920000000003	0.10495360751760106
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0021193920000000003	0.10495360751760106
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.0021193920000000003	0.10495360751760106
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021193920000000003	0.10495360751760106
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.0021193920000000003	0.10495360751760106
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.0021193920000000003	0.10495360751760106
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.0021193920000000003	0.10495360751760106
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.0021193920000000003	0.10495360751760106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0021193920000000003	0.10495360751760106
Pierpont syndrome	0.0021193920000000003	0.10495360751760106
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.0021193920000000003	0.10495360751760106
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.0021193920000000003	0.10495360751760106
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.0021193920000000003	0.10495360751760106
MEVALONIC ACIDURIA; MEVA	0.0021193920000000003	0.10495360751760106
HOLOPROSENCEPHALY 2; HPE2	0.0021193920000000003	0.10495360751760106
CHROMOSOME 1P36 DELETION SYNDROME	0.0021193920000000003	0.10495360751760106
HOLOPROSENCEPHALY 11	0.0021193920000000003	0.10495360751760106
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0021193920000000003	0.10495360751760106
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0021193920000000003	0.10495360751760106
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.0021193920000000003	0.10495360751760106
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.0021193920000000003	0.10495360751760106
Xq28 (MECP2) duplication	0.0021193920000000003	0.10495360751760106
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.0021193920000000003	0.10495360751760106
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0021193920000000003	0.10495360751760106
RING CHROMOSOME 14 SYNDROME	0.0021193920000000003	0.10495360751760106
OPTIC ATROPHY 11; OPA11	0.0021193920000000003	0.10495360751760106
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0021193920000000003	0.10495360751760106
LIG4 SYNDROME	0.0021193920000000003	0.10495360751760106
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0021193920000000003	0.10495360751760106
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.0021193920000000003	0.10495360751760106
KLEEFSTRA SYNDROME 2; KLEFS2	0.0021193920000000003	0.10495360751760106
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0021193920000000003	0.10495360751760106
CHROMOSOME 19p13.13 DELETION SYNDROME	0.0021193920000000003	0.10495360751760106
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.0021193920000000003	0.10495360751760106
CHROMOSOME 1p35 DELETION SYNDROME	0.0021193920000000003	0.10495360751760106
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.0021193920000000003	0.10495360751760106
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0021193920000000003	0.10495360751760106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.0021193920000000003	0.10495360751760106
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0021193920000000003	0.10495360751760106
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0021193920000000003	0.10495360751760106
LISSENCEPHALY 4	0.0021193920000000003	0.10495360751760106
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0021193920000000003	0.10495360751760106
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0021193920000000003	0.10495360751760106
GENITOPATELLAR SYNDROME; GTPTS	0.0021193920000000003	0.10495360751760106
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.0021193920000000003	0.10495360751760106
AL-RAQAD SYNDROME; ARS	0.0021193920000000003	0.10495360751760106
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.10495360751760106
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.0021193920000000003	0.10495360751760106
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.0021193920000000003	0.10495360751760106
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.0021193920000000003	0.10495360751760106
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.0021193920000000003	0.10495360751760106
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0021193920000000003	0.10495360751760106
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.0021193920000000003	0.10495360751760106
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0021193920000000003	0.10495360751760106
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.0021193920000000003	0.10495360751760106
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.0021193920000000003	0.10495360751760106
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.0021193920000000003	0.10495360751760106
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0021193920000000003	0.10495360751760106
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0021193920000000003	0.10495360751760106
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.10495360751760106
BETA-UREIDOPROPIONASE DEFICIENCY	0.0021193920000000003	0.10495360751760106
ADAMS-OLIVER SYNDROME 3; AOS3	0.0021193920000000003	0.10495360751760106
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0021193920000000003	0.10495360751760106
Leukotriene C4 synthase deficiency	0.0021193920000000003	0.10495360751760106
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.0021193920000000003	0.10495360751760106
BARATELA-SCOTT SYNDROME	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0021193920000000003	0.10495360751760106
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.0021193920000000003	0.10495360751760106
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.0021193920000000003	0.10495360751760106
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.0021193920000000003	0.10495360751760106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0021193920000000003	0.10495360751760106
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.0021193920000000003	0.10495360751760106
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.0021193920000000003	0.10495360751760106
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0021193920000000003	0.10495360751760106
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.0021193920000000003	0.10495360751760106
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0021193920000000003	0.10495360751760106
FORSYTHE-WAKELING SYNDROME; FWS	0.0021193920000000003	0.10495360751760106
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0021193920000000003	0.10495360751760106
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.0021193920000000003	0.10495360751760106
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.0021193920000000003	0.10495360751760106
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.0021193920000000003	0.10495360751760106
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0021193920000000003	0.10495360751760106
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.10495360751760106
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.0021193920000000003	0.10495360751760106
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0021193920000000003	0.10495360751760106
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.0021193920000000003	0.10495360751760106
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.0021193920000000003	0.10495360751760106
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.0021193920000000003	0.10495360751760106
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0021193920000000003	0.10495360751760106
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0021193920000000003	0.10495360751760106
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.0021193920000000003	0.10495360751760106
DYSTONIA 28, CHILDHOOD-ONSET	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0021193920000000003	0.10495360751760106
PETERS-PLUS SYNDROME; PTRPLS	0.0021193920000000003	0.10495360751760106
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0021193920000000003	0.10495360751760106
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.0021193920000000003	0.10495360751760106
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.0021193920000000003	0.10495360751760106
HADZISELIMOVIC SYNDROME	0.0021193920000000003	0.10495360751760106
SECKEL SYNDROME 9; SCKL9	0.0021193920000000003	0.10495360751760106
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.0021193920000000003	0.10495360751760106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.0021193920000000003	0.10495360751760106
Mental retardation, autosomal dominant 21	0.0021193920000000003	0.10495360751760106
HOLOPROSENCEPHALY 5; HPE5	0.0021193920000000003	0.10495360751760106
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0021193920000000003	0.10495360751760106
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.0021193920000000003	0.10495360751760106
ADAMS-OLIVER SYNDROME 1; AOS1	0.0021193920000000003	0.10495360751760106
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.0021193920000000003	0.10495360751760106
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.0021193920000000003	0.10495360751760106
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0021193920000000003	0.10495360751760106
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.0021193920000000003	0.10495360751760106
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.0021193920000000003	0.10495360751760106
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0021193920000000003	0.10495360751760106
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0021193920000000003	0.10495360751760106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.0021193920000000003	0.10495360751760106
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.0021193920000000003	0.10495360751760106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.0021193920000000003	0.10495360751760106
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0021193920000000003	0.10495360751760106
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0021193920000000003	0.10495360751760106
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0021193920000000003	0.10495360751760106
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0021193920000000003	0.10495360751760106
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.0021193920000000003	0.10495360751760106
ALAZAMI-YUAN SYNDROME	0.0021193920000000003	0.10495360751760106
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0021193920000000003	0.10495360751760106
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0021193920000000003	0.10495360751760106
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.0021193920000000003	0.10495360751760106
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0021193920000000003	0.10495360751760106
AICARDI-GOUTIERES SYNDROME 7	0.0021193920000000003	0.10495360751760106
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.0021193920000000003	0.10495360751760106
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0021193920000000003	0.10495360751760106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0021193920000000003	0.10495360751760106
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.0021193920000000003	0.10495360751760106
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.0021193920000000003	0.10495360751760106
COFFIN-SIRIS SYNDROME 1; CSS1	0.0021193920000000003	0.10495360751760106
LISSENCEPHALY 8; LIS8	0.0021193920000000003	0.10495360751760106
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0021193920000000003	0.10495360751760106
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.0021193920000000003	0.10495360751760106
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0021193920000000003	0.10495360751760106
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.0021193920000000003	0.10495360751760106
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.0021193920000000003	0.10495360751760106
HEART AND BRAIN MALFORMATION SYNDROME	0.0021193920000000003	0.10495360751760106
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0021193920000000003	0.10495360751760106
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.0021193920000000003	0.10495360751760106
Congenital disorder of glycosylation, type IIh	0.0021193920000000003	0.10495360751760106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0021193920000000003	0.10495360751760106
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.0021193920000000003	0.10495360751760106
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.0021193920000000003	0.10495360751760106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0021193920000000003	0.10495360751760106
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.0021193920000000003	0.10495360751760106
WITTEVEEN-KOLK SYNDROME	0.0021193920000000003	0.10495360751760106
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0021193920000000003	0.10495360751760106
MACDERMOT-WINTER SYNDROME	0.0021193920000000003	0.10495360751760106
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00127551	0.0631640470119616
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00127551	0.0631640470119616
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00127551	0.0631640470119616
LATHOSTEROLOSIS	0.00127551	0.0631640470119616
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00127551	0.0631640470119616
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00127551	0.0631640470119616
#614673 MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	0.00127551	0.0631640470119616
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00127551	0.0631640470119616
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00127551	0.0631640470119616
JOHANSON-BLIZZARD SYNDROME; JBS	0.00127551	0.0631640470119616
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00127551	0.0631640470119616
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00127551	0.0631640470119616
MECKEL SYNDROME 12; MKS12	0.00127551	0.0631640470119616
ENCEPHALOMALACIA, MULTILOCULAR	0.00127551	0.0631640470119616
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00127551	0.0631640470119616
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00127551	0.0631640470119616
FACIOCARDIOMELIC SYNDROME	0.00127551	0.0631640470119616
FEINGOLD SYNDROME 1; FGLDS1	0.00127551	0.0631640470119616
3MC SYNDROME 1	0.00127551	0.0631640470119616
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00127551	0.0631640470119616
CHROMOSOME Xp11.3 DELETION SYNDROME	0.00127551	0.0631640470119616
Angelman syndrome (Type 2)	0.00127551	0.0631640470119616
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00127551	0.0631640470119616
#609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	0.00127551	0.0631640470119616
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.00127551	0.0631640470119616
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00127551	0.0631640470119616
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00127551	0.0631640470119616
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00127551	0.0631640470119616
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.00127551	0.0631640470119616
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00127551	0.0631640470119616
BLOOM SYNDROME	0.00127551	0.0631640470119616
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00127551	0.0631640470119616
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00127551	0.0631640470119616
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00127551	0.0631640470119616
#614852 MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9	0.00127551	0.0631640470119616
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00127551	0.0631640470119616
FOCAL DERMAL HYPOPLASIA; FDH	0.00127551	0.0631640470119616
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00127551	0.0631640470119616
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00127551	0.0631640470119616
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.00127551	0.0631640470119616
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00127551	0.0631640470119616
TEEBI-SHALTOUT SYNDROME; TBSH	0.00127551	0.0631640470119616
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00127551	0.0631640470119616
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.00127551	0.0631640470119616
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00127551	0.0631640470119616
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00127551	0.0631640470119616
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.00127551	0.0631640470119616
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00127551	0.0631640470119616
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.00127551	0.0631640470119616
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00127551	0.0631640470119616
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.00127551	0.0631640470119616
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00127551	0.0631640470119616
MASA SYNDROME	0.00127551	0.0631640470119616
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00127551	0.0631640470119616
LISSENCEPHALY 3; LIS3	0.00127551	0.0631640470119616
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00127551	0.0631640470119616
VELOCARDIOFACIAL SYNDROME	0.00127551	0.0631640470119616
WARBURG MICRO SYNDROME 1	0.00127551	0.0631640470119616
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.00127551	0.0631640470119616
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.00127551	0.0631640470119616
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00127551	0.0631640470119616
601453 TRICHODENTAL DYSPLASIA	0.00127551	0.0631640470119616
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00127551	0.0631640470119616
MEIER-GORLIN SYNDROME 5; MGORS5	0.00127551	0.0631640470119616
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00127551	0.0631640470119616
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00127551	0.0631640470119616
SECKEL SYNDROME 2; SCKL2	0.00127551	0.0631640470119616
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00127551	0.0631640470119616
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00127551	0.0631640470119616
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00127551	0.0631640470119616
MICROHYDRANENCEPHALY; MHAC	0.00127551	0.0631640470119616
MEIER-GORLIN SYNDROME 3; MGORS3	0.00127551	0.0631640470119616
PERRAULT SYNDROME 3	0.00127551	0.0631640470119616
CORNELIA DE LANGE SYNDROME 1	0.00127551	0.0631640470119616
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00127551	0.0631640470119616
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.00127551	0.0631640470119616
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00127551	0.0631640470119616
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00127551	0.0631640470119616
XFE PROGEROID SYNDROME; XFEPS	0.00127551	0.0631640470119616
FONTAINE PROGEROID SYNDROME; FPS	0.00127551	0.0631640470119616
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.00127551	0.0631640470119616
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00127551	0.0631640470119616
LARYNGEAL ABDUCTOR PARALYSIS	0.00127551	0.0631640470119616
BOWEN-CONRADI SYNDROME	0.00127551	0.0631640470119616
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00127551	0.0631640470119616
Diamond-Blackfan anemia 1	0.00127551	0.0631640470119616
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00127551	0.0631640470119616
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00127551	0.0631640470119616
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00127551	0.0631640470119616
ROBERTS SYNDROME; RBS	0.00127551	0.0631640470119616
MARDEN-WALKER SYNDROME	0.00127551	0.0631640470119616
FANCONI ANEMIA	0.00127551	0.0631640470119616
CHARGE SYNDROME	0.00127551	0.0631640470119616
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00127551	0.0631640470119616
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00127551	0.0631640470119616
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00127551	0.0631640470119616
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00127551	0.0631640470119616
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00127551	0.0631640470119616
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00127551	0.0631640470119616
MEIER-GORLIN SYNDROME 8; MGORS8	0.00127551	0.0631640470119616
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00127551	0.0631640470119616
SECKEL SYNDROME 5; SCKL5	0.00127551	0.0631640470119616
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00127551	0.0631640470119616
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00127551	0.0631640470119616
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00127551	0.0631640470119616
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.00127551	0.0631640470119616
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00127551	0.0631640470119616
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.00127551	0.0631640470119616
MARTSOLF SYNDROME	0.00127551	0.0631640470119616
HYPERREFLEXIA	0.00127551	0.0631640470119616
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00127551	0.0631640470119616
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00127551	0.0631640470119616
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00127551	0.0631640470119616
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00127551	0.0631640470119616
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.00127551	0.0631640470119616
FEINGOLD SYNDROME 2; FGLDS2	0.00127551	0.0631640470119616
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.00127551	0.0631640470119616
SECKEL SYNDROME 10; SCKL10	0.00127551	0.0631640470119616
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00127551	0.0631640470119616
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00127551	0.0631640470119616
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00127551	0.0631640470119616
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00127551	0.0631640470119616
MENTAL RETARDATION, X-LINKED 63	0.00127551	0.0631640470119616
AICARDI SYNDROME; AIC	0.00127551	0.0631640470119616
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.00127551	0.0631640470119616
MECKEL SYNDROME, TYPE 4; MKS4	0.00127551	0.0631640470119616
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00127551	0.0631640470119616
COFFIN-SIRIS SYNDROME 10; CSS10	0.00127551	0.0631640470119616
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.00127551	0.0631640470119616
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00127551	0.0631640470119616
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00127551	0.0631640470119616
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00127551	0.0631640470119616
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00127551	0.0631640470119616
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00127551	0.0631640470119616
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00127551	0.0631640470119616
NIJMEGEN BREAKAGE SYNDROME	0.00127551	0.0631640470119616
1q21.1 recurrent microdeletion (susceptibility locus for neurodevelopmental disorders)	0.00127551	0.0631640470119616
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00127551	0.0631640470119616
MOWAT-WILSON SYNDROME; MOWS	0.00127551	0.0631640470119616
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00127551	0.0631640470119616
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00127551	0.0631640470119616
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00127551	0.0631640470119616
Miller-Dieker syndrome (MDS)	0.00127551	0.0631640470119616
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00127551	0.0631640470119616
MICROCEPHALY-CARDIOMYOPATHY	0.00127551	0.0631640470119616
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00127551	0.0631640470119616
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00127551	0.0631640470119616
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00127551	0.0631640470119616
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00127551	0.0631640470119616
Cri du Chat Syndrome (5p deletion)	0.00127551	0.0631640470119616
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.00127551	0.0631640470119616
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00127551	0.0631640470119616
CYCLIC VOMITING SYNDROME	0.00127551	0.0631640470119616
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00127551	0.0631640470119616
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00127551	0.0631640470119616
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00127551	0.0631640470119616
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00127551	0.0631640470119616
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00127551	0.0631640470119616
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00127551	0.0631640470119616
#613630 COCOON SYNDROME;;FETAL ENCASEMENT SYNDROME	0.00127551	0.0631640470119616
STROMME SYNDROME; STROMS	0.00127551	0.0631640470119616
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00127551	0.0631640470119616
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00127551	0.0631640470119616
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00127551	0.0631640470119616
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00127551	0.0631640470119616
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.00127551	0.0631640470119616
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00127551	0.0631640470119616
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.00127551	0.0631640470119616
BRANCHIOOCULOFACIAL SYNDROME	0.00127551	0.0631640470119616
NEU-LAXOVA SYNDROME 2; NLS2	0.00127551	0.0631640470119616
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00127551	0.0631640470119616
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00127551	0.0631640470119616
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00127551	0.0631640470119616
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00127551	0.0631640470119616
Myhre syndrome	0.00127551	0.0631640470119616
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00127551	0.0631640470119616
KLEEFSTRA SYNDROME	0.00127551	0.0631640470119616
#256520 NEU-LAXOVA SYNDROME; NLS	0.00127551	0.0631640470119616
ACHALASIA-MICROCEPHALY SYNDROME	0.00127551	0.0631640470119616
COFFIN-LOWRY SYNDROME; CLS	0.00127551	0.0631640470119616
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00127551	0.0631640470119616
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.00127551	0.0631640470119616
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.00127551	0.0631640470119616
FILIPPI SYNDROME; FLPIS	0.00127551	0.0631640470119616
SECKEL SYNDROME 7; SCKL7	0.00127551	0.0631640470119616
LAMBOTTE SYNDROME	0.00127551	0.0631640470119616
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00127551	0.0631640470119616
YUNIS-VARON SYNDROME	0.00127551	0.0631640470119616
MICROPHTHALMIA, SYNDROMIC 1	0.00127551	0.0631640470119616
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00127551	0.0631640470119616
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00127551	0.0631640470119616
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00127551	0.0631640470119616
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00127551	0.0631640470119616
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00127551	0.0631640470119616
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.00127551	0.0631640470119616
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.00127551	0.0631640470119616
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00127551	0.0631640470119616
Wolf-Hirschhorn Syndrome	0.00127551	0.0631640470119616
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00127551	0.0631640470119616
CRI-DU-CHAT SYNDROME	0.00127551	0.0631640470119616
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00127551	0.0631640470119616
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00127551	0.0631640470119616
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00127551	0.0631640470119616
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00127551	0.0631640470119616
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00127551	0.0631640470119616
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00127551	0.0631640470119616
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00127551	0.0631640470119616
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00127551	0.0631640470119616
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00127551	0.0631640470119616
INCONTINENTIA PIGMENTI; IP	0.00127551	0.0631640470119616
PSEUDOTRISOMY 13 SYNDROME	0.00127551	0.0631640470119616
MEIER-GORLIN SYNDROME 6; MGORS6	0.00127551	0.0631640470119616
MEIER-GORLIN SYNDROME 2; MGORS2	0.00127551	0.0631640470119616
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00127551	0.0631640470119616
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.00127551	0.0631640470119616
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00127551	0.0631640470119616
MEIER-GORLIN SYNDROME 1; MGORS1	0.00127551	0.0631640470119616
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.00127551	0.0631640470119616
MENTAL RETARDATION, X-LINKED 102	0.00127551	0.0631640470119616
HALLERMANN-STREIFF SYNDROME; HSS	0.00127551	0.0631640470119616
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00127551	0.0631640470119616
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00127551	0.0631640470119616
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00127551	0.0631640470119616
FRONTONASAL DYSPLASIA 2; FND2	0.00127551	0.0631640470119616
SUPRABULBAR PARESIS, CONGENITAL	0.00127551	0.0631640470119616
GAUCHER DISEASE, PERINATAL LETHAL	0.00127551	0.0631640470119616
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00127551	0.0631640470119616
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00127551	0.0631640470119616
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00127551	0.0631640470119616
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00127551	0.0631640470119616
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00127551	0.0631640470119616
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00127551	0.0631640470119616
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00127551	0.0631640470119616
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.00127551	0.0631640470119616
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00127551	0.0631640470119616
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00127551	0.0631640470119616
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.00127551	0.0631640470119616
9q subtelomeric deletion syndrome	0.00127551	0.0631640470119616
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00127551	0.0631640470119616
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00127551	0.0631640470119616
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00127551	0.0631640470119616
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.00127551	0.0631640470119616
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00127551	0.0631640470119616
MENKES DISEASE	0.00127551	0.0631640470119616
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.00127551	0.0631640470119616
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00127551	0.0631640470119616
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00127551	0.0631640470119616
Angelman syndrome (Type 1)	0.00127551	0.0631640470119616
OCULOPALATOCEREBRAL SYNDROME	0.00127551	0.0631640470119616
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00127551	0.0631640470119616
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00127551	0.0631640470119616
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00127551	0.0631640470119616
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00127551	0.0631640470119616
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00127551	0.0631640470119616
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00127551	0.0631640470119616
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.00127551	0.0631640470119616
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00127551	0.0631640470119616
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00127551	0.0631640470119616
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00127551	0.0631640470119616
PAINE SYNDROME	0.00127551	0.0631640470119616
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00127551	0.0631640470119616
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00127551	0.0631640470119616
#615328 SHAHEEN SYNDROME; SHNS	0.00127551	0.0631640470119616
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00127551	0.0631640470119616
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00127551	0.0631640470119616
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00127551	0.0631640470119616
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00127551	0.0631640470119616
OROFACIODIGITAL SYNDROME I; OFD1	0.00127551	0.0631640470119616
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00127551	0.0631640470119616
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00127551	0.0631640470119616
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00127551	0.0631640470119616
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00127551	0.0631640470119616
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00127551	0.0631640470119616
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00127551	0.0631640470119616
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00127551	0.0631640470119616
RHIZOMELIC SYNDROME	0.00127551	0.0631640470119616
ALLAN-HERNDON-DUDLEY SYNDROME	0.00127551	0.0631640470119616
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00127551	0.0631640470119616
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00127551	0.0631640470119616
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00127551	0.0631640470119616
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00127551	0.0631640470119616
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00127551	0.0631640470119616
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00127551	0.0631640470119616
SECKEL SYNDROME 1; SCKL1	0.00127551	0.0631640470119616
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.00127551	0.0631640470119616
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.00127551	0.0631640470119616
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.00127551	0.0631640470119616
MECKEL SYNDROME, TYPE 1; MKS1	0.00127551	0.0631640470119616
PITT-HOPKINS SYNDROME	0.00127551	0.0631640470119616
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00127551	0.0631640470119616
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00127551	0.0631640470119616
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.00127551	0.0631640470119616
RENPENNING SYNDROME 1; RENS1	0.00127551	0.0631640470119616
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00127551	0.0631640470119616
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00127551	0.0631640470119616
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00127551	0.0631640470119616
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00127551	0.0631640470119616
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00127551	0.0631640470119616
15q24 recurrent microdeletion syndrome	0.00127551	0.0631640470119616
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00127551	0.0631640470119616
#615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	0.00127551	0.0631640470119616
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00127551	0.0631640470119616
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00127551	0.0631640470119616
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00127551	0.0631640470119616
SECKEL SYNDROME 4	0.00127551	0.0631640470119616
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00127551	0.0631640470119616
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00127551	0.0631640470119616
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00127551	0.0631640470119616
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00127551	0.0631640470119616
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00127551	0.0631640470119616
JACOBSEN SYNDROME	0.00127551	0.0631640470119616
DE SANCTIS-CACCHIONE SYNDROME	0.00127551	0.0631640470119616
COHEN SYNDROME	0.00127551	0.0631640470119616
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00127551	0.0631640470119616
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00127551	0.0631640470119616
OCULODENTODIGITAL DYSPLASIA; ODDD	0.00127551	0.0631640470119616
#614485 TRIGONOCEPHALY 2; TRIGNO2;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.0631640470119616
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00127551	0.0631640470119616
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00127551	0.0631640470119616
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.0631640470119616
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00127551	0.0631640470119616
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00127551	0.0631640470119616
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00127551	0.0631640470119616
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00127551	0.0631640470119616
BARDET-BIEDL SYNDROME 20	0.00127551	0.0631640470119616
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00127551	0.0631640470119616
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00127551	0.0631640470119616
ADDUCTED THUMBS SYNDROME	0.00127551	0.0631640470119616
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00127551	0.0631640470119616
2p15-16.1 microdeletion syndrome	0.00127551	0.0631640470119616
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00127551	0.0631640470119616
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00127551	0.0631640470119616
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00127551	0.0631640470119616
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.00127551	0.0631640470119616
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00127551	0.0631640470119616
RUVALCABA SYNDROME	0.00127551	0.0631640470119616
GERODERMA OSTEODYSPLASTICUM; GO	0.00127551	0.0631640470119616
SWEENEY-COX SYNDROME; SWCOS	0.000843882	0.04178956050563945
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000843882	0.04178956050563945
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.04178956050563945
JOUBERT SYNDROME 14	0.000843882	0.04178956050563945
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000843882	0.04178956050563945
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000843882	0.04178956050563945
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.000843882	0.04178956050563945
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.04178956050563945
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.04178956050563945
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.04178956050563945
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000843882	0.04178956050563945
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.04178956050563945
DIGEORGE SYNDROME; DGS	0.000843882	0.04178956050563945
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000843882	0.04178956050563945
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000843882	0.04178956050563945
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.000843882	0.04178956050563945
Muenke syndrome	0.000843882	0.04178956050563945
CURRY-JONES SYNDROME	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.000843882	0.04178956050563945
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.04178956050563945
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000843882	0.04178956050563945
NIEMANN-PICK DISEASE, TYPE C2	0.000843882	0.04178956050563945
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000843882	0.04178956050563945
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.04178956050563945
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.04178956050563945
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000843882	0.04178956050563945
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000843882	0.04178956050563945
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.04178956050563945
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.000843882	0.04178956050563945
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.000843882	0.04178956050563945
TARP SYNDROME; TARPS	0.000843882	0.04178956050563945
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000843882	0.04178956050563945
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000843882	0.04178956050563945
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.04178956050563945
HARTNUP DISORDER	0.000843882	0.04178956050563945
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.04178956050563945
ELSAHY-WATERS SYNDROME; ESWS	0.000843882	0.04178956050563945
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000843882	0.04178956050563945
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000843882	0.04178956050563945
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000843882	0.04178956050563945
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000843882	0.04178956050563945
JOUBERT SYNDROME 15	0.000843882	0.04178956050563945
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.04178956050563945
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.04178956050563945
#300555 DENT DISEASE 2	0.000843882	0.04178956050563945
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000843882	0.04178956050563945
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.04178956050563945
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000843882	0.04178956050563945
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000843882	0.04178956050563945
JOUBERT SYNDROME 7	0.000843882	0.04178956050563945
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.04178956050563945
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.000843882	0.04178956050563945
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.000843882	0.04178956050563945
JOUBERT SYNDROME 6	0.000843882	0.04178956050563945
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.04178956050563945
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.000843882	0.04178956050563945
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000843882	0.04178956050563945
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000843882	0.04178956050563945
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000843882	0.04178956050563945
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000843882	0.04178956050563945
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000843882	0.04178956050563945
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000843882	0.04178956050563945
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.04178956050563945
#614976 CARPENTER SYNDROME 2; CRPT2	0.000843882	0.04178956050563945
COFFIN-SIRIS SYNDROME 7; CSS7	0.000843882	0.04178956050563945
CDAGS SYNDROME	0.000843882	0.04178956050563945
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.04178956050563945
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.04178956050563945
JOUBERT SYNDROME 35; JBTS35	0.000843882	0.04178956050563945
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.000843882	0.04178956050563945
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000843882	0.04178956050563945
Cerebral creatine deficiency syndrome 3	0.000843882	0.04178956050563945
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.000843882	0.04178956050563945
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000843882	0.04178956050563945
LYMPHEDEMA, HEREDITARY, III	0.000843882	0.04178956050563945
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.000843882	0.04178956050563945
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.000843882	0.04178956050563945
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000843882	0.04178956050563945
ROIFMAN-CHITAYAT SYNDROME	0.000843882	0.04178956050563945
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000843882	0.04178956050563945
FOLATE MALABSORPTION, HEREDITARY	0.000843882	0.04178956050563945
AU-KLINE SYNDROME; AUKS	0.000843882	0.04178956050563945
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000843882	0.04178956050563945
RICHARDS-RUNDLE SYNDROME; RRNS	0.000843882	0.04178956050563945
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000843882	0.04178956050563945
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.000843882	0.04178956050563945
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000843882	0.04178956050563945
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000843882	0.04178956050563945
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.04178956050563945
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.04178956050563945
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000843882	0.04178956050563945
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000843882	0.04178956050563945
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000843882	0.04178956050563945
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000843882	0.04178956050563945
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.000843882	0.04178956050563945
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.04178956050563945
PEROXISOME BIOGENESIS DISORDER 3B	0.000843882	0.04178956050563945
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.04178956050563945
ARIMA SYNDROME	0.000843882	0.04178956050563945
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000843882	0.04178956050563945
MENTAL RETARDATION, X-LINKED 88	0.000843882	0.04178956050563945
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.04178956050563945
ELEJALDE DISEASE	0.000843882	0.04178956050563945
MENTAL RETARDATION, X-LINKED 9	0.000843882	0.04178956050563945
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.04178956050563945
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.000843882	0.04178956050563945
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000843882	0.04178956050563945
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.04178956050563945
RITSCHER-SCHINZEL SYNDROME 1	0.000843882	0.04178956050563945
STEEL SYNDROME; STLS	0.000843882	0.04178956050563945
NOONAN SYNDROME 9; NS9	0.000843882	0.04178956050563945
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000843882	0.04178956050563945
GAUCHER DISEASE, TYPE II	0.000843882	0.04178956050563945
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.04178956050563945
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000843882	0.04178956050563945
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.000843882	0.04178956050563945
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.000843882	0.04178956050563945
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.04178956050563945
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.04178956050563945
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000843882	0.04178956050563945
Helsmoortel-van der Aa syndrome	0.000843882	0.04178956050563945
JOUBERT SYNDROME 28	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.04178956050563945
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000843882	0.04178956050563945
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000843882	0.04178956050563945
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000843882	0.04178956050563945
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.04178956050563945
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000843882	0.04178956050563945
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.04178956050563945
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000843882	0.04178956050563945
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.000843882	0.04178956050563945
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000843882	0.04178956050563945
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000843882	0.04178956050563945
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.04178956050563945
NOONAN SYNDROME 3; NS3	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000843882	0.04178956050563945
JOUBERT SYNDROME 8	0.000843882	0.04178956050563945
CHROMOSOME 9P DELETION SYNDROME	0.000843882	0.04178956050563945
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000843882	0.04178956050563945
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000843882	0.04178956050563945
GABA-TRANSAMINASE DEFICIENCY	0.000843882	0.04178956050563945
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000843882	0.04178956050563945
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000843882	0.04178956050563945
CHAR SYNDROME	0.000843882	0.04178956050563945
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000843882	0.04178956050563945
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.000843882	0.04178956050563945
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000843882	0.04178956050563945
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000843882	0.04178956050563945
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000843882	0.04178956050563945
JOUBERT SYNDROME 31; JBTS31	0.000843882	0.04178956050563945
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000843882	0.04178956050563945
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000843882	0.04178956050563945
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000843882	0.04178956050563945
CHROMOSOME 16p13.2 DELETION SYNDROME	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.04178956050563945
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000843882	0.04178956050563945
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.04178956050563945
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.04178956050563945
COFFIN-SIRIS SYNDROME 2; CSS2	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000843882	0.04178956050563945
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000843882	0.04178956050563945
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000843882	0.04178956050563945
PRADER-WILLI SYNDROME; PWS	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.04178956050563945
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000843882	0.04178956050563945
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000843882	0.04178956050563945
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.04178956050563945
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.04178956050563945
MENTAL RETARDATION, X-LINKED 103	0.000843882	0.04178956050563945
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.04178956050563945
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000843882	0.04178956050563945
PETTIGREW SYNDROME	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000843882	0.04178956050563945
CULLER-JONES SYNDROME; CJS	0.000843882	0.04178956050563945
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.04178956050563945
GRISCELLI SYNDROME, TYPE 1	0.000843882	0.04178956050563945
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000843882	0.04178956050563945
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000843882	0.04178956050563945
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.04178956050563945
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000843882	0.04178956050563945
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000843882	0.04178956050563945
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.04178956050563945
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000843882	0.04178956050563945
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000843882	0.04178956050563945
CHROMOSOME 5Q12 DELETION SYNDROME	0.000843882	0.04178956050563945
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.000843882	0.04178956050563945
Retinitis pigmentosa with or without skeletal anomalies	0.000843882	0.04178956050563945
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000843882	0.04178956050563945
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000843882	0.04178956050563945
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000843882	0.04178956050563945
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000843882	0.04178956050563945
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000843882	0.04178956050563945
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000843882	0.04178956050563945
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.04178956050563945
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000843882	0.04178956050563945
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000843882	0.04178956050563945
300270 ADRENOMYODYSTROPHY	0.000843882	0.04178956050563945
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000843882	0.04178956050563945
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000843882	0.04178956050563945
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000843882	0.04178956050563945
SENIOR-LOKEN SYNDROME 9	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000843882	0.04178956050563945
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000843882	0.04178956050563945
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.04178956050563945
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000843882	0.04178956050563945
SHUKLA-VERNON SYNDROME; SHUVER	0.000843882	0.04178956050563945
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000843882	0.04178956050563945
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000843882	0.04178956050563945
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000843882	0.04178956050563945
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000843882	0.04178956050563945
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.04178956050563945
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.000843882	0.04178956050563945
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.04178956050563945
ZTTK SYNDROME; ZTTKS	0.000843882	0.04178956050563945
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.04178956050563945
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.04178956050563945
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000843882	0.04178956050563945
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000843882	0.04178956050563945
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000843882	0.04178956050563945
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000843882	0.04178956050563945
Bardet-Biedl syndrome 2	0.000843882	0.04178956050563945
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000843882	0.04178956050563945
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.04178956050563945
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.04178956050563945
MECKEL SYNDROME 13; MKS13	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000843882	0.04178956050563945
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000843882	0.04178956050563945
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.04178956050563945
WEAVER SYNDROME	0.000843882	0.04178956050563945
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000843882	0.04178956050563945
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000843882	0.04178956050563945
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000843882	0.04178956050563945
RAHMAN SYNDROME	0.000843882	0.04178956050563945
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000843882	0.04178956050563945
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.000843882	0.04178956050563945
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.04178956050563945
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.04178956050563945
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.04178956050563945
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000843882	0.04178956050563945
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.04178956050563945
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.04178956050563945
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.04178956050563945
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000843882	0.04178956050563945
XIA-GIBBS SYNDROME	0.000843882	0.04178956050563945
NOONAN SYNDROME 2; NS2	0.000843882	0.04178956050563945
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.04178956050563945
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000843882	0.04178956050563945
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.04178956050563945
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000843882	0.04178956050563945
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000843882	0.04178956050563945
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000843882	0.04178956050563945
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.04178956050563945
CHOPS SYNDROME; CHOPS	0.000843882	0.04178956050563945
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.000843882	0.04178956050563945
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.000843882	0.04178956050563945
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000843882	0.04178956050563945
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000843882	0.04178956050563945
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000843882	0.04178956050563945
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000843882	0.04178956050563945
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.000843882	0.04178956050563945
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000843882	0.04178956050563945
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.04178956050563945
SEPTOOPTIC DYSPLASIA	0.000843882	0.04178956050563945
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000843882	0.04178956050563945
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.04178956050563945
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000843882	0.04178956050563945
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000843882	0.04178956050563945
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.04178956050563945
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000843882	0.04178956050563945
PALLISTER-HALL SYNDROME	0.000843882	0.04178956050563945
OROTIC ACIDURIA	0.000843882	0.04178956050563945
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000843882	0.04178956050563945
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.04178956050563945
JOUBERT SYNDROME 30; JBTS30	0.000843882	0.04178956050563945
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.04178956050563945
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000843882	0.04178956050563945
HYPERPROLINEMIA, TYPE I	0.000843882	0.04178956050563945
FRIAS SYNDROME	0.000843882	0.04178956050563945
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.04178956050563945
PELLAGRA-LIKE SYNDROME	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000843882	0.04178956050563945
LANDAU-KLEFFNER SYNDROME	0.000843882	0.04178956050563945
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.04178956050563945
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.04178956050563945
JOUBERT SYNDROME 25	0.000843882	0.04178956050563945
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.04178956050563945
EVEN-PLUS SYNDROME	0.000843882	0.04178956050563945
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.04178956050563945
WAARDENBURG-SHAH SYNDROME	0.000843882	0.04178956050563945
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000843882	0.04178956050563945
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000843882	0.04178956050563945
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.04178956050563945
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.04178956050563945
OROFACIODIGITAL SYNDROME VI	0.000843882	0.04178956050563945
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.000843882	0.04178956050563945
JOUBERT SYNDROME 10	0.000843882	0.04178956050563945
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.04178956050563945
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000843882	0.04178956050563945
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000843882	0.04178956050563945
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000843882	0.04178956050563945
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000843882	0.04178956050563945
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000843882	0.04178956050563945
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.04178956050563945
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.000843882	0.04178956050563945
KAGAMI-OGATA SYNDROME	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000843882	0.04178956050563945
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000843882	0.04178956050563945
SCHINDLER DISEASE, TYPE I	0.000843882	0.04178956050563945
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000843882	0.04178956050563945
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.04178956050563945
GALACTOSE EPIMERASE DEFICIENCY	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.04178956050563945
NOONAN SYNDROME 5; NS5	0.000843882	0.04178956050563945
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000843882	0.04178956050563945
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.04178956050563945
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000843882	0.04178956050563945
JOUBERT SYNDROME 27	0.000843882	0.04178956050563945
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.04178956050563945
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000843882	0.04178956050563945
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000843882	0.04178956050563945
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.04178956050563945
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.04178956050563945
NIEMANN-PICK DISEASE, TYPE A	0.000843882	0.04178956050563945
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000843882	0.04178956050563945
XQ25 DUPLICATION SYNDROME	0.000843882	0.04178956050563945
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000843882	0.04178956050563945
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000843882	0.04178956050563945
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000843882	0.04178956050563945
JOUBERT SYNDROME 21	0.000843882	0.04178956050563945
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.04178956050563945
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000843882	0.04178956050563945
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000843882	0.04178956050563945
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.04178956050563945
DESANTO-SHINAWI SYNDROME	0.000843882	0.04178956050563945
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.04178956050563945
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000843882	0.04178956050563945
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000843882	0.04178956050563945
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.04178956050563945
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000843882	0.04178956050563945
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.04178956050563945
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000843882	0.04178956050563945
JOUBERT SYNDROME 26	0.000843882	0.04178956050563945
AUSTRALIA ANTIGEN	0.000843882	0.04178956050563945
NOONAN SYNDROME 6; NS6	0.000843882	0.04178956050563945
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.000843882	0.04178956050563945
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.04178956050563945
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.04178956050563945
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000843882	0.04178956050563945
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000843882	0.04178956050563945
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000843882	0.04178956050563945
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000843882	0.04178956050563945
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.04178956050563945
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000843882	0.04178956050563945
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.000843882	0.04178956050563945
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000843882	0.04178956050563945
DIAPHANOSPONDYLODYSOSTOSIS	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000843882	0.04178956050563945
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.04178956050563945
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000843882	0.04178956050563945
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000843882	0.04178956050563945
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.04178956050563945
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.04178956050563945
COHEN-GIBSON SYNDROME; COGIS	0.000843882	0.04178956050563945
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000843882	0.04178956050563945
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000843882	0.04178956050563945
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000843882	0.04178956050563945
INFANTILE SIALIC ACID STORAGE DISEASE	0.000843882	0.04178956050563945
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000843882	0.04178956050563945
CODAS SYNDROME	0.000843882	0.04178956050563945
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.04178956050563945
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.04178956050563945
HYPEREKPLEXIA 4; HKPX4	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000843882	0.04178956050563945
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000843882	0.04178956050563945
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000843882	0.04178956050563945
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000843882	0.04178956050563945
FRONTOOCULAR SYNDROME	0.000843882	0.04178956050563945
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000843882	0.04178956050563945
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.000843882	0.04178956050563945
TYSHCHENKO SYNDROME	0.000843882	0.04178956050563945
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000843882	0.04178956050563945
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000843882	0.04178956050563945
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000843882	0.04178956050563945
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000843882	0.04178956050563945
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000843882	0.04178956050563945
LAMB-SHAFFER SYNDROME	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000843882	0.04178956050563945
PHACE ASSOCIATION	0.000843882	0.04178956050563945
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.04178956050563945
JOUBERT SYNDROME 2	0.000843882	0.04178956050563945
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000843882	0.04178956050563945
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000843882	0.04178956050563945
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.04178956050563945
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000843882	0.04178956050563945
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.04178956050563945
NOONAN SYNDROME 11; NS11	0.000843882	0.04178956050563945
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.04178956050563945
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000843882	0.04178956050563945
CATEL-MANZKE SYNDROME; CATMANS	0.000843882	0.04178956050563945
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.000843882	0.04178956050563945
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.04178956050563945
611961 STEVENSON-CAREY SYNDROME	0.000843882	0.04178956050563945
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.000843882	0.04178956050563945
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000843882	0.04178956050563945
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000843882	0.04178956050563945
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000843882	0.04178956050563945
#614483 PORENCEPHALY 2; POREN2	0.000843882	0.04178956050563945
SCHAAF-YANG SYNDROME; SHFYNG	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000843882	0.04178956050563945
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.000843882	0.04178956050563945
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000843882	0.04178956050563945
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000843882	0.04178956050563945
Temtamy preaxial brachydactyly syndrome	0.000843882	0.04178956050563945
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.04178956050563945
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.04178956050563945
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000843882	0.04178956050563945
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000843882	0.04178956050563945
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.04178956050563945
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000843882	0.04178956050563945
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000843882	0.04178956050563945
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.04178956050563945
CHROMOSOME 16Q22 DELETION SYNDROME	0.000843882	0.04178956050563945
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.04178956050563945
HURLER SYNDROME	0.000843882	0.04178956050563945
GRACILE BONE DYSPLASIA; GCLEB	0.000843882	0.04178956050563945
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000843882	0.04178956050563945
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000843882	0.04178956050563945
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000843882	0.04178956050563945
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000843882	0.04178956050563945
MENTAL RETARDATION, X-LINKED 72	0.000843882	0.04178956050563945
MENTAL RETARDATION, X-LINKED 90	0.000843882	0.04178956050563945
JOUBERT SYNDROME 24	0.000843882	0.04178956050563945
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.04178956050563945
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.000843882	0.04178956050563945
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.04178956050563945
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000843882	0.04178956050563945
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.04178956050563945
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000843882	0.04178956050563945
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.04178956050563945
CRANIOFRONTONASAL SYNDROME; CFNS	0.000843882	0.04178956050563945
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.04178956050563945
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.04178956050563945
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000843882	0.04178956050563945
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000843882	0.04178956050563945
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.04178956050563945
HOLOPROSENCEPHALY 7	0.000843882	0.04178956050563945
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000843882	0.04178956050563945
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000843882	0.04178956050563945
MEND SYNDROME; MEND	0.000843882	0.04178956050563945
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.04178956050563945
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000843882	0.04178956050563945
Aarskog-Scott syndrome	0.000843882	0.04178956050563945
3MC SYNDROME 2	0.000843882	0.04178956050563945
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.000843882	0.04178956050563945
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000843882	0.04178956050563945
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000843882	0.04178956050563945
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.04178956050563945
BAKER-GORDON SYNDROME; BAGOS	0.000843882	0.04178956050563945
MENTAL RETARDATION, X-LINKED 41	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000843882	0.04178956050563945
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.000843882	0.04178956050563945
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000843882	0.04178956050563945
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000843882	0.04178956050563945
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000843882	0.04178956050563945
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000843882	0.04178956050563945
COACH SYNDROME	0.000843882	0.04178956050563945
COFFIN-SIRIS SYNDROME 6; CSS6	0.000843882	0.04178956050563945
IMMUNODEFICIENCY 49; IMD49	0.000843882	0.04178956050563945
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000843882	0.04178956050563945
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000843882	0.04178956050563945
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000843882	0.04178956050563945
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.04178956050563945
HAREL-YOON SYNDROME; HAYOS	0.000843882	0.04178956050563945
JOUBERT SYNDROME 1	0.000843882	0.04178956050563945
POPOV-CHANG SYNDROME; POPCHAS	0.000843882	0.04178956050563945
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000843882	0.04178956050563945
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.04178956050563945
TEMTAMY SYNDROME; TEMTYS	0.000843882	0.04178956050563945
KETOADIPICACIDURIA	0.000843882	0.04178956050563945
LUSCAN-LUMISH SYNDROME; LLS	0.000843882	0.04178956050563945
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000843882	0.04178956050563945
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000843882	0.04178956050563945
CURRARINO SYNDROME	0.000843882	0.04178956050563945
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.04178956050563945
Cerebral creatine deficiency syndrome 2	0.000843882	0.04178956050563945
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000843882	0.04178956050563945
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000843882	0.04178956050563945
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000843882	0.04178956050563945
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.04178956050563945
